Rohit Chandra is Executive Vice President and Cleveland Clinic’s Chief Digital Officer. In this role, he oversees the Information Technology Division and leads digital innovation throughout Cleveland Clinic’s global health system. Dr. Chandra works to accelerate Cleveland Clinic’s digital transformations in areas including artificial intelligence, machine learning and big data to improve access to care and enhance the patient and caregiver experience.

Previously, Dr. Chandra was Vice President of Engineering at Sunshine Products, a technology startup in Palo Alto, California. In this role, he led the engineering team, leveraging sophisticated algorithms to solve a range of everyday problems and tasks, including the creation of Sunshine Contacts. Prior to that, he was Senior Vice President of Search and Advertising at Verizon Media, where he was responsible for merging products and teams from Yahoo and AOL after their acquisitions by Verizon.

Dr. Chandra holds a bachelor’s degree from the Indian Institute of Technology, Kanpur, India, as well as a doctorate in Computer Science from Stanford University.

Dr. Chandra was a fellow with the TELI (Technical Executive Leadership Initiative) Program. He is the co-author of a book on parallel programming and holds numerous patents.

Dr. Laura Matz serves as the Chief Science and Technology Officer at Merck KGaA Darmstadt, Germany, a role that entails spearheading the innovation agenda of a distinguished science and technology enterprise with a heritage exceeding 350 years in chemistry, biotechnology, and integrated materials solutions. In her capacity, Laura collaborates closely with the Company Board and partners with Innovation Heads across Merck KGaA’s three leading industry verticals: Life Science, Healthcare, and Electronics. Her visionary leadership is instrumental in shaping the future of the enterprise, leveraging digital and AI/ML technologies to drive innovation, exploring new markets, fostering strategic partnerships, and developing cutting-edge capabilities and digital business models to deliver groundbreaking solutions. A recent notable achievement includes her role as CEO in launching Athinia™, a joint venture with Palantir, which introduced a pioneering data collaboration platform for the semiconductor ecosystem. Prior to assuming the role of CSTO, Laura held the position of Senior Vice President within EMD Electronics, previously Versum Materials and Air Products Electronics division. With over 20 years, of experience in semiconductor manufacturing and a decade dedicated to running semiconductor materials businesses, she has been driving force the advancements in the field, prioritizing robust R&D for business expansion. Beyond her role at Merck KGaA, Laura serves on the Board of Directors of transformative organizations. She’s a board member of AIChE (American Institute of Chemical Engineers) and of SEMI. Laura also serves as Director on the board of AION Labs.

Alex’s personal mission is to support the under-privileged, the under-served and make this world a more equitable place.

Alex is currently leading Tencent Healthcare to support healthcare industry’s digital innovation and transformation. Tencent Healthcare currently connects and smoothens the process of accessing online and offline healthcare services for individuals on Tencent Healthcare mini-program, and also provides AI and cloud solutions to health agencies, hospitals, medical institutions, and pharmaceutical companies.

Alex serves as an expert on the WHO Digital Health Technical Advisory Group and Honorary Professor at University of Hong Kong. Before joining Tencent, Alex was the deputy director for Health Innovation and Partnership at the Bill & Melinda Gates Foundation and Associate Partner at McKinsey & Company.

Alex is a trained physician from New Zealand where he served as the chief resident at Middlemore Hospital in Auckland. He received his medical qualifications from University of Auckland, a Master of Public Health from Harvard and Postgraduate Diploma in Health Informatics from University of Otago.

Scott Oloff is an Executive Leader in Roche – pRED (Pharma Research & Early Development), where he has been based in Basel, Switzerland since early 2022. He joined Roche – pRED leading the Data & Analytics organisation to drive all data, analytics, & technology capabilities for the discovery of breakthrough medicines towards unmet patient needs. Prior to joining Roche, he led IT Research, Development, and Medicine Enablement with Boehringer Ingelheim which drove modeling, software platforms, and technology used across biological/chemical pharmaceuticals and animal health, including providing shared tools and data services to support manufacturing.  Scott began his career as a computational chemist working in drug project teams for both Boehringer Ingelheim and Biogen. He has a Ph.D. in Pharmacology from the University of North Carolina, Chapel Hill and a B.S. in Chemical Engineering from Clemson University.  Scott also serves on the Scientific Advisory Boards of BenchSci, CAS (a division of the American Chemical Society), and the PRISME Forum consisting of digital leaders from the top 40 Pharma.

Dr. Tamara Sunbul is a leading figure in healthcare innovation and digital transformation, serving as the Medical Director of Clinical Informatics at Johns Hopkins Aramco Healthcare and chairing the HIMSS Middle East Community Steering Committee. With over 25 years of experience, she has been instrumental in achieving prestigious recognitions for JHAH, including HIMSS Stage 7 EMRAM and CHIME Most Wired Level 9, and has significantly contributed to the global healthcare sector through her roles with the Global Digital Health Platform, the International KLAS Advisory Board, and ZIMAM. Honored with awards and recognitions such as HIMSS Future50 Class clinical leader, the ZIMAM/HIMSS Digital Health Leader of the Year and the Arabian Business KSA Women In Business award, Dr. Sunbul is also a renowned keynote speaker at numerous international stages, advocating for the integration of healthcare and digital technology, and driving forward the fields of healthcare informatics and digital health and leveraging her expertise to redefine healthcare paradigm

Sunil Dadlani is an accomplished global business technology leader who has spent his extensive career in this sector using his expertise to develop and implement complex, global information technology strategies and processes. 

He joined Atlantic Health System in September 2020 and oversees Information Technology systemwide. In this role, Mr. Dadlani continues to advance the system’s use of information technology strategies and platforms to help support the delivery of excellent patient care and team member experiences. One particular focus is the management and continued growth and development of the system’s electronic medical record, Epic.

Prior to joining Atlantic Health System, Mr. Dadlani was the Chief Information Officer for the New York State Department of Health. He successfully led the largest public-sector digital business technology transformation, delivering digital health care services to 19 million New Yorkers.

Prior to this, Mr. Dadlani served as the Global Head of Enterprise Business Applications & Digital Transformation at Sony.

Mr. Dadlani earned his MBA in Global Management and a Masters in Computer Science and Information Systems. He is an advisory board member for the NY Health Information Technology (HIT) and Health Information Exchange (HIE).

Dr. Saleem is board certified in Ophthalmology and Clinical Informatics and has gained much experience while working in the healthcare industry. Her role has evolved into being part of thought leadership for health care systems on how to use IT to achieve health system strategic goals.

Her areas of focus have been EMR and Telemedicine implementation and optimization, validation and implementation of artificial intelligence in clinical settings, and managing operational and clinical priorities in ambulatory and inpatient care settings.

As healthcare IT’s role has evolved into being part of thought leadership for health care systems, Dr. Saleem plays a large role in how to manage and govern the use of IT to achieve the strategic goals of the health system. She continues to practice ophthalmology and is a leader in health care digital transformation. Her skills in collaboration have allowed her to successfully implement many programs across complicated healthcare environments.

Dr. Ozanan R. Meireles serves as the inaugural Vice Chairman of Innovation at Duke University School of Medicine’s Department of Surgery and the Surgical Director of Duke AI Health. He specializes in minimally invasive and endoluminal surgery and leads the Surgical AI and Innovation Laboratory (SAIIL). His collaborative work through SAIIL with prestigious institutions like MIT’s Computer Science and Artificial Intelligence Laboratory, Massachusetts General Hospital, the University of Cologne, and Duke Health is central to pioneering advancements in AI-enhanced surgery, aiming for its integration into surgical practices imminently.

Dr. Meireles earned his medical degree from São Paulo State University in Brazil, completed surgical training at Michigan State University, and pursued a research fellowship at Johns Hopkins University focusing on NOTES (natural orifice transluminal endoscopic surgery), robotics, and augmented reality in surgery. He further specialized in Minimally Invasive Surgery at the University of California, San Diego. After dedicating 13 years to Massachusetts General Hospital and Harvard Medical School as a bariatric and foregut surgeon and the Director of SAIIL-MGH, Dr. Meireles joined Duke University in January 2024.

His research is devoted to leveraging artificial intelligence, including computer vision and foundational models, to improve operational efficiency, enhance surgical outcomes, reduce healthcare costs, and democratize surgical knowledge. He has made significant contributions to the development and application of minimally invasive techniques in gastrointestinal surgery.

Internationally recognized, Dr. Meireles has chaired the SAGES Artificial Intelligence Task Force Committee and led international efforts to establish standards for the sustainability and scalability of surgical AI.

Massimo is a result driven Senior Technology Leader with experience across Pharmaceutical, Medical Devices and Consumer industries. Currently, as the Head of Technology, Advanced Therapies he is fully responsible for shaping the vision and strategic roadmap for end-to-end digital and technology enablement of the JnJ Advanced Therapies business, across Supply Chain, Commercial, and R&D worldwide. Massimo has more than 20 years extensive experience, driving technology strategies, optimising risk, controls, and availability across critical supply chain and manufacturing operations across the globe. Committed to people development he has proven cross-cultural team management skills that drive collaboration and engagement. Highly adaptable, career achievements include, next to mayor function leadership, experience mentoring technology start-up in Europe.

Joland Rutgers is Vice President and Health of Innovation Excellence at Philips. He has 30 years of experience at the company and was promoted to his current role in May 2023. Joland focuses on developing clinical partnerships to deeply understand the needs of its customers, accelerating meaningful innovations to market and elevating excellence for critical capabilities related to Data & AI, Software, Systems Engineering, Product Management and Product Development.

During his 30-year career at Philips, Joland has been responsible for R&D for various business units such as DXR, OEM, MR, Diagnostic Imaging and Precision Diagnostic platforms. He has experience using AI for meaningful solutions including VitalEye, SmartSpeed, MR Workspace and Predictive Serviceability.

In 2020, Joland won Philips’ CEO Innovation Award for his focus on driving high-quality and new innovative propositions to market such as the world’s only sealed MR 1.5T scanner. He also won NYU Facebook challenge with MR fast speed solutions resulting in the MR SmartSpeed proposition powered by AI.

Antonio is the Innovation leader and heads Deloitte’s Strategy and Analytics in Switzerland. His team helps clients leverage the power of artificial intelligence and data to inform client strategies, and deliver more customer centric products and services that catalyse growth and efficiencies. 

He has over 20 years of experience in advising companies in large scale global transformations leveraging new delivery models (GBS/SSC, Outsourcing) and innovative technologies (e.g., Machine Learning, Natural Language Processing/Generation, GenAI). He helped global organizations in the private sector review and implement new strategies for Business Support solutions, and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

John is the Global Head of Digital Ethics and Compliance at Takeda who is leading a team of experts responsible for enabling Takeda’s use of data, digital and technology in an ethical and responsible manner. The scope includes data ethics, data privacy, use of AI, and social media. 

John has over 20 years of experience in technology, digital, data privacy, and information security & risk management and has worked with multi-national companies in tech, banking, fintech, and consulting industry.

He is an accomplished data, digital, ethics risk and compliance leader who is passionate about how information technology ethically empowers humanity in a sustainable manner.

Dr. Nicolas Löffler-Perez is a Data Scientist at Swissmedic, the Swiss Agency for therapeutic products. After obtaining his Ph.D at The Johns Hopkins University, he moved to Switzerland to work on Clinical Machine Leaning in the University Hospital of Zurich and the University of Zurich where he developed a multimodal model for comprehensive analysis of images and reports in the hospital as well as optimization algorithms among other projects. He currently works with the Swissmedic 4.0 Team as the technical lead in multiple AI-based applications including the search of illegal medicinal substances in e-commerce, medicament recognition from images, and document similarity. His work focuses in innovation and the implementation of new technologies within Swissmedic. These solutions are mostly oriented towards the improvement of processes at Swissmedic making the stakeholder’s engagement essential for the success of these innovative solutions.

Manuel is a Senior C-Level executive and Board Member with more than 20 years’ experience in innovation, technology and digital transformation in healthcare at an international level, working for large corporations and startups companies.  He is accustomed to working for different sectors and clients, both public and private, including private equity firms.

Manuel has extensive experience in Digital Health and Innovation, Technology, Data Analytic, New Business Models and Startups, IT Cloud Operations and large-scale Integration, Transformation and Resiliency Programs, including: due diligence, acquisitions, divestitures, implementations of Digital and Core Healthcare Systems, Data Center migrations and consolidations, and Cloud operations and migrations, all at international Level.

He is recognised for strong ethical convictions and is accustomed to working with multicultural teams and international companies, making them grow in a challenging environment. Manuel also has extensive experience in government relations management and public administration.

For the last 25 years he has worked in diverse and exciting positions, constantly learning, and innovating and always providing companies with innovation and new competitive advantages.

He loves healthcare and has always been trusted to have the best interests of the company, employees, and customers at heart as well as  delivering on commitment.

Dr. Shelby Kutty’s career has included serving in the roles of physician-scientist, clinician, and academic leader. As Helen Taussig professor, he conceived and developed a cardiovascular analytic intelligence program at Johns Hopkins. One of the world’s preeminent experts on multimodal cardiovascular imaging with consistent grant funding and over 450 peer-reviewed publications, Dr. Kutty is passionate about patient outcomes and evidence-based assessment of new technologies. He has a master’s degree in healthcare management from Harvard University, training in healthcare artificial intelligence from Massachusetts Institute of Technology, and is an Aresty Scholar of the Wharton School at the University of Pennsylvania.

Sara is the Head of Data and Analytics at Galen Growth, bringing over a decade of experience in the medical device industry, spanning both corporate environments and startups. Before joining Galen Growth, she played a pivotal role in a scale-up focused on connecting a medical device to a mobile app, collaborating closely with a leading pharmaceutical company and a major tech firm. Sara’s passion for analytics and data-driven decision-making has been a driving force throughout her career, helping to navigate the complexities of developing digital health solutions and fostering impactful partnerships between ventures and pharma. Galen Growth is a pioneering global digital think tank advancing digital health innovation.

Prof. Peter van Ooijen, MSc, PhD, CPHIMS is an informatician working in the field of Artificial Intelligence in Healthcare. He is a full Professor in AI in Radiotherapy and Machine Learning Expert & coordinator of the machine learning lab of the Data Science Center in Health (DASH). Both positions are at the University Medical Center Groningen in Groningen, the Netherlands. He (co)authored over 190 PubMed enlisted papers and more than 25 book chapters. He is the 2023-2024 president of the European Society of Medical Imaging Informatics (EuSoMII).

Ms. Vink is the Director of the Smart Health Tech Center (SHTC) of Erasmus MC.  SHTC focuses on the integration, development, testing and validation of technologies for health and healthcare. SHTC contributes to advancements in healthcare technology, enabling better patient outcomes and improving the overall healthcare landscape. In addition to her role at SHTC, Ms. Vink is also the Director of Research Development Office (RDO) of Erasmus MC. RDO offers a range of funding application-related services for research, innovation and education to promote (inter)national cooperation and financing.

Before Ms. Vink joined Erasmus MC in 2016, she was Business Director of the UNESCO-IHE Water Institute in Delft. Before that, from 2007 onwards, she worked as Special Advisor & Program Manager EU / Government relations at the Delft University of Technology (TU Delft). Until then, she was Head of the Technical and Scientific Attaches Network of the Ministry of Economic Affairs in the Netherlands. Prior to that, she worked as senior policy advisor European research and technology policy for the Ministry of Economic Affairs. She also worked as Director Liaison Office at the University of Amsterdam (UvA) and as a research and training advisor for the United Nations (FAO & UNHCR).

In addition to her job at Erasmus MC, Ms. Vink advises the Netherlands AI Coalition (NLAIC) on European Affairs and UN Women Netherlands on Public Affairs.

Felice Burn is a data science innovation expert in healthcare, medical doctor, clinical researcher and leader of an AI and Data Science CoE at Cantonal Hospital Aarau in Switzerland. With more than 20 years healthcare experience and more than 12 years’ experience in development and integration of artificial intelligence in healthcare. He designed and implemented new AI strategies and AI Governances, has extensive experience in digitalization, big data projects and AI driven solutions to support and optimize healthcare processes to gain important business values for healthcare institutions

Alexander has 18 years of experience partnering with Global Life Sciences executives developing and deploying product launch strategies and transforming functions such as Market Access & Pricing, Marketing & Digital Customer Engagement and Evidence Generation. He has broad therapeutic area experience, ranging from oncology over cardiovascular, inflammation to rare diseases, designing go-to-market strategies and patient pathway innovation. Alexander leads Switzerland’s Strategy and Business Design practice and serves as Consulting Industry Lead for Life Sciences in Switzerland.

Matt is currently a Senior Project Manager and the Digital Experience Lead for the New Campus Development of The Ottawa Hospital (TOH). He leads the equipment and digital experience planning, alongside his team. He also sits with TOH’s Digital Solution’s leadership team to ensure strategic alignment between the project planning activities and current strategic priorities. Prior to this, he held regional and leadership positions in clinical operations for trauma and critical care. He also had the privilege to serve our Inuit population as a flight nurse in the Canadian Arctic.  

He is a critical care nurse with a master’s in healthcare quality from Queen’s University. He also earned a certificate on Artificial Intelligence in Healthcare from TH Chan School of Public Health at Harvard University. He prioritizes patient & staff experience as primary drivers to his work, committed to ensuring a clinical lens is prioritized early in the planning processes. He joined the TOH’s new campus planning team in January 2022. Shortly after, he joined the Canadian Standards Association to draft national standards for digital infrastructure and digital health technologies in healthcare facilities. 

Professor Noam Shomron is passionate about using basic science to advance better healthcare. Professor Shomron heads the Functional Genomic Team at the Faculty of Medical and Health Sciences at Tel Aviv University after training at MIT. He leads a multidisciplinary team of scientists that develops computational methods for parsing big data in the bio-medical field using Artificial Intelligence (AI). Shomron applied for over 30 patents and published over 200 peer-reviewed publications on multiple genomic fields, including medicine, agriculture, and business. Shomron also leads the Tel Aviv University Innovation Lab (TILabs) Team on Digital Medicine. He is the Editor of ‘Deep Sequencing Data Analysis’ book (Springer, Edition I 2013, and II 2021); Director of ‘Rare-Genomics’ Israel (NPO); Director of Djerassi Institute of Oncology; Academic Director of ‘ScienceAbroad’ (NPO); Co-founder of several Biotech and Digital Medicine companies: Variantyx, GotSho, IdentifAI, Everly Bio, among others. Website: https://nshomron.github.io/

Sofia Couto da Rocha is a MD with long-standing experience in the field. She dedicates herself to innovation, digital transformation and smart aging using technology as a streamline for precision medicine. She completed her MBA at The Lisbon MBA, a minor in Political Science from NOVA and a BA in Design in London. Masters in longevity related subjects in four universities. After earned a scholarship for the IWI at MIT engineering Boston and one for Clinical Research from Harvard Medical School, she focused her research in innovation and technology for healthcare. Awarded in Biotechnology, Leadership and Digital, among others the Global Impact Challenge of Singularity University, which made her last startup kick off in Silicon Valley at the NASA Campus, the SAGES Clinical Services 2021 Shining Bright, leading the best 2023 innovation project for healthcare by the European private hospitals association – Lusi.

She was the president of the IT commission of the initiative Health Parliament Portugal for 3 years, being currently Medical officer at Patient Innovation and Untech, and a member of the council for information Technologies of the National Medical Council.

As a fighter for equal opportunities, she was invited to be part of the women Leaders global forum, since 2018. Nowadays, teaches about innovation and new technologies applied to healthcare.

Nowadays, Sophia leads innovation and the virtual Client at Lusíadas Saúde, one of the largest private health groups in Portugal, part of Vivalto Santé.

Eric is a Partner in the Deloitte Cyber Risk Services team and currently acting as Digital Trust & Privacy co-leader in Deloitte Switzerland and within EMEA.

He has over 25+ years of experience advising companies on cross-border, data protection & privacy, digital trust technologies (inc.l AI implementations) & data management challenges as well as related data and digital regulation requirements. Eric leads complex compliance projects for major organizations across all industries but with a specific focus on Life sciences industry. 

He has somewhat of a hybrid background as he is both a lawyer as well as a security professional. Eric is an active member of several AI, data protection steering committees and focusses on the practical/technical and compliance related aspects of AI and data protection challenges. His clients typically describe him as someone bringing clarity in chaos, a bridge builder and an intrapreneur with a strong passion for pragmatic data governance.

As Senior Product Manager, Andrea has been shaping product vision since the establishment of BSI’s Artificial Intelligence Regulatory Services business area. By defining how BSI can support companies in development and deployment of AI systems, Andrea is committed to bring his contribute to a virtuous future for AI.

Caoimhe is an experienced pharmaceutical executive and clinical strategy specialist with a focus on digital health. She provides strategic development and go-to-market guidance to innovative digital health start-ups. Previously, she held senior positions at Merck KGaA, Roche Pharmaceuticals, and others. A trained geneticist and biomedical scientist, she holds an MSc in Translational Medicine and is pursuing a PhD at University College London. She has previously collaborated with the World Economic Forum on genomic testing and technology in healthcare, and is currently working with DayOne to accelerate innovative start-ups with a healthtech focus.

John Marshall is Co-founder and CEO of Airia, an enterprise AI, full-stack platform.  Prior to Airia, John founded and built AirWatch to be the global leader in enterprise mobility management with over 20,000 customers and $250M in recurring revenue.  After VMware acquired AirWatch in 2014, John helped his former employees launch and scale OneTrust, an enterprise privacy platform with over 14,000 customers.

Data Manager at EIT Health, a prestigious Knowledge and Innovation Community of the European Institute of Innovation and Technology (EIT) and coordinator of SkillSync (a tool for upskilling and foster innovation) within the EIT AI Community. Prior to this, professor at Universitat Politècnica de Catalunya (UPC) and researcher on Personalized Computational Medicine. Additionally, I founded and served as CEO of an SME headquartered at the Barcelona Science Park, contributing to advancements in clinical decision support systems. My career has been marked by a steadfast commitment to fostering innovation and collaboration in the fields of healthcare, academia, and technology management. My areas of expertise encompass personalized computational medicine, distributed systems, and eHealth. I hold a Ph.D. in Network Engineering and BSC in Computer Science at UPC. MSc in Information and Knowledge Society and Diploma of Advanced Studies in Informatics Systems and Languages (DEA) at UOC.

Bart has over 20 years experience in clinical research and development in several roles, always supporting the development of innovative products. He has been actively focusing on developing innovative partnerships in data science (artificial intelligence, machine learning, big data and e-health) and is affiliated to the UMCG Innovation Center and the Data Science Center in Health (DASH). He is also president of the Dutch Clinical Research Foundation and president of the Dutch Association of Contract Research Organizations. His activities focus on connecting excellent science to an extensive network in private industry and develop innovative public private partnerships to achieve UMCG’s strategic goals.

Dr. Raul Villamarin Rodriguez, Vice President of Woxsen University, is a Cognitive Technologist and Adjunct Professor at Universidad del Externado, Colombia. He serves as a member of the International Advisory Board at IBS Ranepa, Russian Federation, and holds positions on the Advisory Boards of PUCPR, Johannesburg Business School, SA, Milpark Business School, South Africa, PetThinQ Inc, and SpaceBasic, Inc. Additionally, Dr. Rodriguez is a Visiting Professor at Uni. del Rosario and an Expert at UNESCO.

Karine Lavoie is a distinguished global health care leader with a passion for healthcare professional development, who work for the international council of Nurses as Head of Partnerships and Programmes Development. Working with ICN’s is more than 135 national nursing associations members globally and representing the 29 million of nurses worldwide. To deliver programme and partnership initiatives that further the cause of nursing through advocacy and improved health care practices and patient care. 

With a strategic and innovative mindset, Karine has played a pivotal role in shaping the future of health care education and steering transformative initiatives in various health care organizations. As a Nursing Program Innovator and Coordinator in academia, Karine crafted pioneering curricula for nurses and established multiple simulation centres as global benchmarks but also develop technologies for the medical device industry. Her unwavering commitment to enhancing safety for health care professionals has been a cornerstone of her endeavours. Karine is driven by a keen interest in refining health care environments, leveraging technology and AI and research to optimize existing health care systems, always guided by a vision of continual improvement and a commitment to maximizing effective and efficient health care outcomes.

Bill DeWeese is Co-founder and CTO of Airia, a pioneering enterprise AI platform for data and document processing and intelligent workflows. Prior to Airia, Bill was part of the advanced R&D team at AirWatch, contributing to its growth and $1.54B acquisition by VMware in 2014. He then founded Aviation Mobile Apps, driving mobile application development for the aerospace industry. Bill’s innovative work has resulted in 30 U.S. Patents and applications. With nearly three decades in the tech industry, he leads the development of multimodal AI systems leveraging cutting-edge NLP, computer vision, and machine learning technologies. He has completed executive Business Strategy and Entrepreneurship programs at Cornell University and advanced AI and Machine Learning programs at MIT. As an accomplished private pilot, Bill brings a unique perspective to the intersection of AI, aviation, and mobile technologies.

As the Director of Customer Experience & Insights (CXI), Panos leads the newly created CXI division at Intelligencia AI. He focuses on unlocking value for the company’s partners through best-in-class thought partnerships and bespoke analytics that harness the company’s proprietary data.

He brings over a decade of experience in the life sciences industry, helping North American and European pharmaceutical and biotech companies develop products, therapeutic areas and portfolio strategies. Before joining Intelligencia AI, Panos was a Principal with Strategic Decisions Group, a management consulting firm focusing on decision-making. Before moving into strategy consulting and the health tech industry, he began his career in the energy sector. He is an engineer by training with a background in economics, finance and decision analysis.

Panos holds a master’s of sciences in management science and engineering from Stanford University, a master’s of sciences in energy production and management, as well as a master’s of engineering in electrical engineering and computer science from the National Technical University of Athens. He is a Fulbright Scholar.

Panos is also a business mentor who coaches technology startups in developing their business plans and serves on the Greek Alumni Association of Stanford University board. In his leisure time, he enjoys reading literature, participating in sports and spending time with friends.

Stephan, trained as a computer scientist and biomedical engineer, brings a wealth of experience to his role as an engineer and project lead. He operates at the intersection of human and computer vision, leaving a significant impact on various ophthalmology and optometry projects over the past 15 years. Currently, Stephan serves as a project lead at Helbling Technik, a globally-active Swiss contract engineering company. He strongly believes in holistic and risk-driven product development, and his unwavering commitment to creating effective solutions for real-world challenges drives his work.

Joseph Zabinski, PhD, MEM is VP, Head of Commercial Strategy & AI at OM1. He oversees design, implementation, and evolution of OM1’s commercial strategy, including prioritization, go-to-market planning, and alignment with emergent market needs. Dr. Zabinski also serves as subject matter expert and thought leader for OM1’s AI work, including applications of the PhenOM digital phenotyping platform with life science and healthcare provider partners. Prior to joining OM1, Dr. Zabinski was a consultant in the Pharmaceutical and Medical Products Practice at McKinsey & Co. He specialized in advising life science and healthcare clients on using AI and advanced analytics, including identification of unmet medical needs, portfolio optimization, and AI strategy. His academic research focused on applications of Bayesian network modeling methods to predicting and stratifying environmental human health risk. Dr. Zabinski holds a master’s degree in engineering management from Dartmouth College, and a doctorate with a focus in health analytics from the School of Public Health at the University of North Carolina, Chapel Hill. Dr. Zabinski is a 2023 Healthcare Innovation 40 Under 40 Winner.

Rebecca completed all but one of the courses required of the PhD in pure mathematics at Yale University when unfortunately family illness necessitated an extended leave. This experience was a catalyst to Rebecca’s subsequent founding of the digital health therapeutics company Orange Therapeutics. Rebecca has been sponsored at a number of prestigious math conferences, including: “Automorphic Forms” at Institut Henri Poincaré; a summer at the Institut des Hautes Études Scientifiques in France; two months at the conference “Modular Forms” at the Isaac Newton Institute in Cambridge in the UK; and, more recently, “Around Functional Transcendence” at the Mathematics Institute, the University of Oxford. Prior to grad school Rebecca had worked for a software firm and had done the detail design and led the implementation of a ship inspection system for a foreign government. One of six female entrepreneurs interviewed for a Forbes article, Rebecca is the leader of, and the creative mind behind, Orange Therapeutics.

Chris Guyer is the Group Vice President for North America and Europe at RxPx.  Chris has over 25 years of experience servicing the healthcare industry from leading organizations such as Johnson & Johnson, Novartis, Epocrates, Phreesia, Paro AI, and Truveris.  Chris is a trusted senior advisor and leader to commercial teams across the industry and has helped these teams evaluate innovative strategies, platforms and approaches for the purpose of improving efficiency, productivity and quality.  Chris’s current purview includes leading commercial strategy and client relationships across the portfolio of partnerships that RxPx has in North America and Europe.

Lucas Scherdel is a neuroscientist, health tech executive, board advisor and published academic with a passion for health innovation and technology. Previously he led Switzerland’s leading health tech accelerator, DayOne, founding a seed fund and leading to investments in 50+ deep tech ventures. He also led Bayer Consumer Health’s R&D portfolio for local brands and external innovation as a Global Vice President. He has previously led the World Economic Forum’s Global Coalition for Value in Healthcare and its executive board which represents $350 billion of global market share and has advised multiple VC funds, startups, academic and public institutions such as the World Health Organization, UK’s NHS, UCL Business School and the European Institute for Innovation and Technology. Lucas is currently a supervisory board member of EIT Health and was named on the Forbes List 30 under 30 in 2020 and has been featured in the Guardian and Forbes and published as an author for the Lancet, WHO, WEF, UNEP and Health Tech World.

Iris is a dedicated Consultant and Strategic Advisor, currently serving as Forum Lead at Etheros HealthData Foundation. Etheros is committed to empowering individuals with ownership of their health data, fostering a more inclusive and equitable global healthcare system.

With a strong foundation in data management, rare disease early diagnosis, and value-based healthcare, Iris has a proven track record of driving innovative healthcare solutions. Her previous roles at Takeda, IBM, and SAP have equipped her with deep insights into the industry’s challenges and opportunities.

Dr. Haider Raza is a Senior Lecturer in Artificial Intelligence at the University of Essex. He holds a PhD from the University of Ulster, focusing on adaptive learning in EEG-based brain-computer interfaces. His research interests span machine learning, computer vision, and explainable AI, with a particular emphasis on healthcare applications. Dr Raza has held research positions at the University of Ulster and Swansea University Medical School before joining Essex in 2017. With over £3.3 million in research funding and 20+ peer-reviewed journal publications, his work significantly advances AI-driven diagnostic algorithms and decision-making processes in healthcare.

Roland Rott is President & CEO of GE HealthCare Ultrasound & Cardiology, a global leader that has defined ultrasound innovation for over 25 years. In this role, Roland is responsible for driving the growth and innovation of the ~$3 billion business with more than 3000 employees worldwide. In his tenure leading the Ultrasound & Cardiology segment he has presided over the acquisition of surgical visualization & guidance pioneer BK Medical, the company’s largest acquisition since 2017, the equity investment in at-home ultrasound start-up Pulsenmore and the acquisition of AI healthcare leader Caption Health. Since joining GE HealthCare, Roland has held senior roles Ultrasound IT and Women’s Health, and prior to his appointment as President & CEO of Ultrasound, served as General Manager of Women’s Health Ultrasound, where he grew the strategic business unit to become the market leader in obstetrics/gynecology worldwide. Before joining GE HealthCare, Roland was Managing Director, Europe, Middle East & Africa (EMEA) and executive board member at Exact Software— a mid-cap public company headquartered in the Netherlands— leading four R&D teams and subsidiaries in 20 countries. Early in his career Roland was an entrepreneur who founded two successful software companies in Austria that were later acquired by strategic investors. Roland earned his post-secondary diploma (HTL) in Engineering with specialization in Information Technology & Business Administration from HTBLA Leonding in Austria, studied International Business Administration at Leopold-Franzens Universität Innsbruck, and has completed executive education programs at Stanford University, London Business School, and the University of California at Berkley. He lives in Vienna, Austria with his wife and three children.

Mona is the Global Head of Medical AI at NVIDIA. She brings a unique perspective with her varied experience in clinical medicine, medical applications, and business. She is a board-certified cardiac surgeon and the previous Chief Medical Officer of a digital health company. She holds an MBA in Management Information Systems, and has worked on Wall Street. Her ultimate goal is the betterment of medicine through AI.

Elena Bonfiglioli is Microsoft’s Global Business Leader for Healthcare, Pharma and Life Sciences. She is in the DIA Advisory Council and Vice Chair of the DIGITALEUROPE Digital Health Executive Council. In this capacity she is responsible for industry strategy and commercial go-to-market, enabling co-innovation and strategic partnerships to accelerate transformation with cloud and AI.

Dr. Ozanan Meireles is an Assistant Professor of Surgery at Harvard Medical School and a Bariatric, Foregut, and Advanced Endoluminal Surgeon at the Massachusetts General Hospital in Boston. Dr. Meireles has been practicing surgery at MGH for more than 10 years, where he has been responsible for the introduction of new technologies and techniques. 

Dr Meireles graduated from the Sao Paulo State University School of Medicine in Brazil. He completed his surgical training at Michigan State University and his clinical fellowship in Minimally Invasive and Bariatric Surgery at the University of California San Diego. He spent his research fellowship at the Johns Hopkins Hospital investigating augmented reality in surgery, robotic telemanipulation, and Natural Orifices Trans Endoluminal Surgery (NOTES).

He is the director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital. At SAIIL, his research focus is on utilizing computer vision to investigate the intraoperative phase of care through real-time, automated surgical analysis and provide surgeons with additional data, with the goals of democratization of surgical knowledge, lowering costs, improving patient outcomes, and reduction of morbidity and mortality. 

He serves as the Chairman of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Artificial Intelligence Task Force, where he has been leading several projects to research and build the foundation for the scalability and sustainability of Surgical AI.

Meet Aisha Rahim, a seasoned healthcare executive with over a decade of international leadership and board-level experience. A Harvard-educated professional, Aisha is highly skilled in medical advisory, scientific strategy, and patient safety. She has a strong track record of developing clinical quality improvement processes, providing pharmaceutical solutions, and enhancing patient outcomes. Aisha’s focus on Tech equity and healthcare equity has placed her among the esteemed board members of the American Diabetes Association for the DC MD VA chapters. Plus, she’s a tech-savvy individual who has completed education in artificial intelligence at MIT and business process design improvement at MIT. Aisha is an accomplished communicator, expert trainer, and skilled leader, adept at building and strengthening relationships across functions to drive cohesive, strategic operations.

Aquil Harjivan is the R&D Head of Digital Health at Bayer CH. Aquil is a scientist by training and has been in the FMCG and the consumer healthcare industries for all his career across P&G, Unilever, GSK and now Bayer.

Passionate about people and technology, he’s spent his career across innovation and product roles understanding what drives human behaviour in healthcare and how science and technology can be leveraged to solve it. Since joining Bayer in 2021, Aquil has led the digital health strategy and is now leading the Precision Health business unit announced earlier this year to develop and deliver new products and services that expand the role of the Bayer brands across the healthcare journey.

Nicholas Kelley is the Director Data Science & A.I. Portfolio Strategy and Innovation in the central Novartis Data & AI organization, and has two main priorities.  First, to identify, prioritise, and launch key use-cases with the mission of delivering reusable AI capabilities for the scientific and medical core of the business.  Second, to better define the AI opportunities landscape and needed capabilities across the value chain.  Here the key focus is on continued improvement of our Novartis data science foundation through innovative partnerships and by leading the data science community and capability building initiatives.

Recent initiatives include seeding and driving AI solutions such as Generative Chemistry as part of the partnership with Microsoft Research, the first cross-Novartis Data Science challenge in collaboration with MIT, and launching the AI for Life Residency program.

Nick has a formal background in computational methodology with a Ph.D. in Biophysics from Stanford University, with career experience in computational biology, chem- and bioinformatics, and most recently in the application of A.I. and machine learning in health.  

Dr Sujoy Kar is the Chief Medical Information Officer and the Vice-President of Apollo Hospitals, previously Medical Director of Apollo Gleneagles Hospitals, Kolkata. He is a Clinical Microbiologist by background with subsequent post graduations from Indian Statistical Institute and MIT Sloan School of Management. He is an Adjunct Faculty for Healthcare Analytics and Management at IIM Calcutta and IIT Kharagpur. His current and ongoing research interests are in the development and adoption of Artificial Intelligence in Healthcare and Digital Health Platforms.

Katie Baca Motes’ expertise includes digital health, strategic partnerships, negotiation, clinical trial enrollment, decentralized clinical trial structure, remote patient/participant monitoring, patient motivations, incentive structure, and behavioral economics. She’s passionate about bringing communities together to tackle health challenges, improving representation in research, and decreasing health disparities.

She brings 14 years of experience running large-scale research programs. She’s known for bringing innovation to the field of clinical research; for example, bringing the practice of A/B testing to build the mSToPs study cohort, one of the first remote site-less clinical trials. As the Co-Investigator and Director (2016-2021) of The Participant Center component of the All of Us Research Program (administered by the National Institutes of Health), she led the teams who built out a national infrastructure that enables “anyone, anywhere” to enroll in the program and she led innovations in digital and community-level engagement and in participant retention practices. She’s partnered in pioneering efforts such as working on some of the first studies to utilize patient-mediated EHR capture via SMART on FHIR. In early 2020, she co-founded the Scripps Digital Trials Center and launched DETECT, a COVID-19 research platform using wearable data for early detection and understanding progression of disease, factors for Long COVID, and vaccine response. In 2021, she launched the PowerMom Consortium, focused on accelerating maternal health research and decreasing health disparities.

Professor Shafi Ahmed is a world renowned, multi award winning surgeon, teacher, futurist, innovator and entrepreneur. He is a 3x TEDx speaker and has delivered over 300 keynotes in 35 countries.

After studying  medicine at Kings College Hospital Medical School London, he completed his surgical training in London. He is currently a Laparoscopic Colorectal surgeon at The Royal London and St Bartholomew’s Hospitals.

He has received multiple Professorships and Honorary doctorates and was a Nobel Peace prize nominee in 2020 for his humanitarian work in conflict zones. In 2018 he was awarded the Future NHS award for NHS70 by Members of Parliament. In 2017 he was the top British Asian star in Tech. He was also the British Bangladeshi of the Year 2017

He is currently a member of the NHS Assembly advising on the NHS long term plan and has previously been an advisor to the Abu Dhabi Ministry of Health.  He is currently the Vodafone Connected Health 5G Ambassador for the UK and sits on the board of The Centre for Health, a joint venture with Vodafone and Deloitte. He sits on the board of advisors at Abilitii in Saudi Arabia building health for Vision 2030 and is a Non Exec Director at the Considered, a global health marketing agency.

He is the Co Founder of Medical Realities, an award winning XR medical education company and was appointed as the Chief Medical Metaverse Officer at AIMEDIS who are building the world’s first health metaverse. He also cofounded GIANT Health the largest medtech conference in the UK. 

As a previous Associate Dean at Barts Medical School, Shafi disrupting the traditional medical school curriculum by launching the Barts X Medicine Programme in 2015. Shafi has embedded future technologies and entrepreneurship into the medical school. 

As an advocate for equality and a passion for humanitarian projects, he recently launched the Shafi Ahmed Foundation International. This foundation aims to provide relief and aid to those in need whilst promoting access to medical training.

Dr. Darren Gates is a senior Registrar in Paediatric Intensive Care at Alder Hey Children’s Hospital, Liverpool, UK. In addition to his clinical practice he works as a Clinical Innovation Consultant in the Trust’s award winning Innovation Hub where he is clinical lead for the artificial intelligence workstream. This includes The Living Hospital project, a partnership with the Science and Technology Foundation Council’s (STFC) Hartree Centre and IBM, working to improve patient care and experience.

Susan Tillmann leads Data, Analytics and Digital for Global Manufacturing & Supply at Takeda Pharmaceuticals International AG. The digital and data executive with over 16 years’ experience in pharma, successfully leads the achievement of perceived previously unattainable goals leveraging Artificial Intelligence, Data, XR and Hyperautomation.

Alberto Tozzi is a distinguished pediatrician and epidemiologist renowned for his expertise in vaccines and his contributions to the surveillance and prevention of infectious diseases. With over 15 years of dedicated research at the Italian National Public Health Institute, he has focused extensively on developing effective vaccination strategies. Throughout his career, he has collaborated closely with esteemed organizations such as the World Health Organization and the European Centers for Disease Control in their joint efforts to combat infectious diseases worldwide. In 2004, Dr. Tozzi transitioned to the Bambino Gesù Children’s Hospital, assuming key roles in the prevention of infectious diseases, telemedicine, and innovation in pediatrics. Currently, he serves as the Head of the Predictive and Preventive Medicine Research Unit, where his work revolves around pioneering projects that explore the integration of artificial intelligence into pediatric medicine and the advancement of related training initiatives. Notably, as a corresponding member of the Pontifical Academy for Life, Dr. Tozzi actively addresses the ethical implications of technological advancements in the field of pediatrics. His involvement in this institution showcases his commitment to the responsible and conscientious application of technology in healthcare. Additionally, Dr. Tozzi currently holds the position of President of the International Society for Pediatric Innovation, further demonstrating his leadership and dedication to fostering innovation and progress in pediatric healthcare on a global scale.

Elisabeth obtained her PhD in Process Engineering, Bioprocesses and Applied Mathematics from the University of Montpellier, France in 2004 with over six publications, followed by several recognition awards in data and process analytics used for process design, optimization, monitoring and control. 

Over 19 years of experience in Pharma Industry, the knowledge gained in various roles across development, quality, regulatory and manufacturing, combined with previous experience in academia , leading new technology design and implementation, developing quantitative and predictive AI algorithms to optimize processes and enable real-time analysis, evaluating new business development opportunities (asset, digital therapies, technologies) across all development stages, ensuring compliance using a quality by design, science and risk- based approach considering patient safety, allowed to gain a deep understanding of Pharmaceutical Industry with the ability to foster effective collaboration across divisions, functions and countries.

Clare Bornstein acts as advanced analytics platform lead for Global Manufacturing & Supply at Takeda Pharmaceuticals International AG. 

Peter is Head of Analytics, Data & AI at the Novartis Foundation, accelerating the use of data and analytics as part of the Foundation’s mission to improve population health and inequities. Before that, Peter co-founded Novartis AG’s transformational data42 program which enables the use of the company’s deep pre-clinical, clinical, and real world data to accelerate and improve drug R&D. Prior to his work at Novartis, Peter was Chief Data & Technology Officer at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle. He managed the data for the Global Burden of Disease (GBD) study and created IHME’s global public data catalog Global Health Data Exchange (GHDx) and innovative interactive data visualizations.

Matthias Pfister is Head of the Development Team at Helbling Technik, a worldwide active, independent Swiss contract engineering company. He has 15 years of professional experience in the development of innovative technologies and products for medical applications. Matthias Pfister has successfully managed the development of several medical devices, from ideation until FDA approval. He is currently heading a development team whose core competence is processing complex signals acquired with optical sensors and systems. Past experiences include various projects in ophthalmology, endoscopy, and dermatology. Independent of the application, Matthias Pfister has a strong focus on a holistic development approach along the signal chain, i.e., from photon generation to digital signal processing. Furthermore, he considers strong systems engineering and project management to be key success factors for development.

Johannes Boch began his professional career as psychologist, working in different research and mental health facilities across Europe. Subsequently he expanded his experiences working with consulting, research and business development for impact investors and entrepreneurs, with a focus on access to healthcare in LATAM. He holds degrees in Psychology from the University of Fribourg (CH), International Affairs and Finance.

At the moment, Johannes is serving his team as the Director of Population Health at the Novartis Foundation. In this capacity he oversees global programs and partnerships in cardiovascular population health and health equity which have benefitted up to 17 million people over the last years and shaped health systems to become more efficient and sustainable.

Gaurica Chacko is a proven industry leader with more than 20 years of experience in management consulting and life sciences, primarily focusing on business and digital transformation, cloud development, health equity, and clinical and commercial strategy. Gaurica works at the intersection of business and technology and specializes in connecting with clients and partners to find innovative solutions to complex business problems.

Prior to joining Wipro, Gaurica was Managing Director at FTI Consulting focusing on health solutions across the healthcare continuum. Previously she was the Regional GM, Global Markets at Quest Diagnostics and prior to that she served as a senior executive at Edwards Lifesciences leading several Global functions including Compliance and Legal Operations, Business Excellence and Clinical Affairs.

Gaurica spent more than a decade in management consulting working for Deloitte and KPMG where she led highprofile strategic engagements in R&D optimization, operational excellence, sales and marketing strategies and M&A due diligence for life science clients.

Gaurica has a passion for bringing innovative therapies and diagnostics to underserved patient populations. She is a champion for Health Equity and an executive member of the WEF-Edison Alliance.

Sofia Martinez is the ad-interim Director of Product Engineering Security at Roche Diagnostics. Her team supports the implementation of cybersecurity and privacy principles across all stages of the product life cycle to a variety of medical devices and digital solutions used in the healthcare sector.

She has experience in developing and establishing product cybersecurity and privacy strategies and she led the re-design of Roche Diagnostics operating model to deliver product cybersecurity and privacy and allow for agility and innovation.

In addition to that, she’s responsible for monitoring the ever-changing regulatory landscape and consolidating new cybersecurity and privacy requirements with the aim of ensuring compliance and continuously improving the security maturity of the company by evolving cybersecurity strategies.

Sofia is currently an active member of the Geneva Dialogue representing the medical device industry. She contributes with her expertise to address the cyber norms and challenges related to reducing vulnerabilities in cyberspace.

As Senior Director of the Digital Ecosystem, Jan’s role is to drive GE HealthCare Digital EMEA’s Ecosystem Strategy and together with his team develop cooperation with partner companies, indirect channels, start-up centers and networks. Jan is the head of GE Healthcare’s Edison Accelerator. With over 15 years of experience in healthcare informatics, the medical imaging domain and management, Jan is a seasoned leader with vast experience in leading strategic initiatives and in fluencing strategic decisions that ultimately drive revenue and contribute to enterprise value.

Prior to joining GE HealthCare, Jan has held consultancy roles in Digital Health start-ups and radiology IT companies. Prior to his Digital Ecosystem responsibility at GE HealthCare, he has been responsible for leading clinical consultancy at GE HealthCare Digital in Europe, Middle East & Africa where he and his team ensured and optimized the quality of clinical solution architecture, clinical work flow consultancy, change management and user adoption.

He brings a real passion for the digital transformation of healthcare, understanding healthcare provider needs, improving healthcare work flows and user experience.

Jan lives outside of Leipzig, Germany, with his wife and their two daughters and founded www.gr4ai.academy, a non-profit to create awareness and educate children around Artificial Intelligence.

Francine has a 25+ year career in leadership roles within both the public and private Healthcare sector, driving efficiencies across all operations and spearheading innovation through new technology.  She is experienced working both in house and as a consultant managing large cross functional teams, accomplished at delivering hospital activation and green field capital projects, improving clinical processes, patient outcomes, compliance, quality & safety, medicines optimization and developing clinical services.  With an international background, she has worked in British, American, Dutch and UAE health care systems and is a Doctor of Pharmacy.

Francine is ambitious and entrepreneurial whilst remaining hands-on to drive results through people.

Most recently, Francine has led on Cleveland Clinic London’s hospital wide operational activation as well as the implementation of a revolutionary fully automated Closed Loop Medicines Optimisation model, the first in the UK, now fully operational within budget and timescale. She was awarded both the Cleveland Clinic CEO team award and Team Innovation award for the successful activation of Cleveland Clinic London. Additionally, her team was nominated for the 2022 Laing Buisson Innovation award for the implementation of Cleveland Clinic London’s unique closed loop medicines management system. She oversaw the hospital’s Epic Medicines Management application, regarded the most successful international implementation of its kind.

Prior to this, as an independent consultant, she led 5 independent hospitals to achieve outstanding CQC ratings and transformed underperforming clinical and operations teams. In this role, she worked with Executive Teams of around 20 hospitals on organizational analyses and improvement strategies to drive inspection success.

She is a former Chief Pharmacist at HCA Healthcare’s Wellington Hospital, having come from Lead Clinical Pharmacy roles at the Cromwell Hospital, leading NHS Trusts and University Hospitals in The Netherlands. She has particular clinical interest in Critical Care and Pediatrics. Francine has served on several boards of Healthcare Organizations.

She holds an Honorary Associate Professorship at The University of Leicester and completed her PharmD and MSc in Clinical Pharmacology at Utrecht & Maastricht University in The Netherlands. In addition, she is an associate advisor at Deloitte, completed a Certificate in Business Administration at Warwick Business School and a Digital Transformation Leadership module at Harvard Medical School.

Francine is married with an 18 year old son and 12 year old daughter. She is a keen traveler, played tennis in the Dutch National League and performs regularly as a flute player.

Francine has a particular interest in voluntary work in Education and served as a Chair of Governors at a school in Surrey. In addition, she was a volunteer Covid vaccinator, having vaccinated 1,200 people at her local Primary Care Network.

Jiangtao Wang is an internationally recognized researcher of AI for Health at Coventry University. His expertise lies in developing novel AI algorithms to analyze complex healthcare data, aiming to improve the accuracy, efficiency, and accessibility of healthcare delivery. Dr. Wang has made significant contributions to the field, creating cutting-edge machine learning models that tackle various health challenges. These include population health monitoring, diagnosis prediction, drug-drug interaction analysis, and COVID severity estimation. Notably, his models have consistently outperformed state-of-the-art methods on real-world clinical datasets, such as the MIMIC-III Database and NHS datasets. His research findings have been published in top AI and data science venues like AAAI, IJCAI, KDD, and ICDM. Dr. Wang’s exceptional work has earned him several prestigious awards and recognitions. In 2021, he was honored with the Engineering and Physical Sciences Research Council’s (EPSRC) New Investigator Award. Additionally, he was selected as a member of the UKRI Future Leader Fellow development network in 2023, highlighting his talent and potential as a leading researcher in his field.

Hermen Jan is a versatile bellwether in innovation, digitalisation and transformation. As Director of Digital Health for UMC Utrecht he All supported by a 24/7 operational and accessible Medical Service Centre providing people-centric digital care services to support, monitor and treat patients in their own living environment.

Dr. Echeverri is a medical doctor with +18 years working experience, combined clinical, disasters’

and public health expertise in complex humanitarian emergencies, protracted crises, and outbreaks

of infectious diseases. She has a keen interest and experience in migration/displaced population health- related operations, programs, and policy.

Dr. Echeverri has worked with various international, governmental, and non-governmental organizations covering a variety of field and executive roles, leading cross-functional teams, health strategy, negotiating access and operational space for health programs, humanitarian responses, projects in development, implementation, and evaluation, with a particular focus on preparedness, readiness,and response. Equally, for the last 5 years she has worked as a consultant for organizations and agencies such as DFID/FCDO, WHO/PAHO, and Geneva Call, in activities related to strategy

and proposal development, monitoring and evaluation of projects, and fostering relationships and

key partnerships.

Dr. Echeverri holds a Master in Disaster Medicine (EMDM) and is as faculty member of the

European Master in Disaster Medicine (EMDM) where she has been supporting the development,

design, and improvement of the complex humanitarian emergencies module of which she is a

senior lecturer for Migration and Health, in addition to playing a role as thesis supervisor. She is

currently a PhD candidate in Global Health, Humanitarian Aid and Disaster Medicine at the

Università del Piemonte Orientale in Novara-Italy, and a Research fellow at CRIMEDIM.

Dr. Echeverri is a member of the Health Care in Danger Initiative working group led by ICRC.

Katrin Crameri is a group leader at SIB and heads the Data Coordination Centre of the Swiss Personalized Health Network (SPHN) – a federal research infrastructure initiative for the efficient and responsible use of health data. She is also chair of the BioMedIT Board, which is responsible for the development and operation of the Swiss Trusted Research Environment. Katrin is a member of various national and international committees in the field of data-driven medicine and is strongly committed to advance better research for better health and to successfully maintaining Switzerland as a high-performing biomedical research location.

Brenna Loufek is the SaMD Regulatory Affairs Manager in the Center for Digital Health – Data & Analytics at Mayo Clinic. Brenna collaborates with user-innovators to create regulatory strategies that offer the least burdensome pathway to market for digital health technologies developed at Mayo Clinic. Her subject matter expertise is in the nuanced application of US FDA regulatory policies for AI/ML-enabled software functionalities.

Brenna brings extensive experience guiding teams through domestic and international regulations and standards. With previous roles at Medtronic and Philips, Brenna has managed complex regulatory submissions and advised on studies for digital health products including AI/ML-based technologies, telehealth platforms, and in-clinic management tools. In addition to program support, Brenna has served as a cross-departmental liaison to provide training for and interpretation of FDA’s current positioning on digital health products.

Brenna has a master’s degree in Patient Safety & Healthcare Quality from Johns Hopkins. She is currently pursuing a PhD in Evidence-Based Healthcare from the University of Oxford with a research focus on the efficacy of regulatory and ethical frameworks within healthcare institutions to manage AI/ML-enabled clinical decision support software.

Felice Burn is a data science innovation expert in healthcare, medical doctor, clinical researcher and leader of an AI and Data Science CoE at Cantonal Hospital Aarau in Switzerland. With more than 20 years healthcare experience and more than 12 years’ experience in development and integration of artificial intelligence in healthcare. He designed and implemented new AI strategies and AI Governances, has extensive experience in digitalization, big data projects and AI driven solutions to support and optimize healthcare processes to gain important business values for healthcare institutions

Aditya Kudumala is a Partner within Deloitte Consulting practice, leads Life Sciences Strategy, AI, and innovation businesses to deliver insights and innovative solutions to drive value for organizations. His primary focus has been in leading and delivering strategy, AI, blockchain, products and technology-enabled transformation initiatives to deliver strategic outcomes.

Helge Buess joined the Novartis Foundation in September 2022 as Associate Director Population Health. He coordinates urban population health initiatives that leverage the power of data and advanced analytics to decipher the true drivers of cardiovascular health and equity.

After roles in Sales and Marketing at Astellas Pharma AG, Helge joined the Oncology Business Unit of Novartis Switzerland in 2018 as Disease Area Manager. In this position, he was responsible for maximizing the commercial growth of products in the local hematology portfolio.

In 2021, Helge was appointed Strategic Assistant to the Swiss Country Head, supporting and driving strategic projects in Novartis’ Pharma Business Unit such as the development of the Country Organisation’s strategic roadmap as well as the design and implementation of transformation projects.

Helge graduated from the Swiss Federal Institute of Technology (ETHZ) with a PhD in Molecular & Cellular Biology and from the University of St. Gallen (HSG) with an Executive MBA in General Management. With his wide range of experience, Helge refers to hands-on expertise in biomedical research, product marketing, matrix leadership, multi-sectorial KOL- and stakeholder management, international project management and strategy building.

The main research interests of Professor Somaya Ben Allouch involve development, use and evaluation of digital technologies, such as robotics and AI. She obtained her PhD at the University of Twente (the Netherlands) and has been a visiting researcher at the Ambient Intelligence Research Lab of Stanford University. 

Since 2021, she has combined the endowed professorship of Human-System Interaction for Health and Wellbeing at the University of Amsterdam, the Netherlands, with heading the Digital Life research team at the Amsterdam University of Applied Sciences. 

She has published several articles in scientific journals, including International Journal of Mobile Human Computer Interaction, Journal of Human-Computer Interaction and Journal of Medical Internet Research, and has been guest editor of the scientific journals International Journal of Distributed Sensor Networks and International Journal of Social Robotics. She is a member of the editorial board of Journal of Ambient Intelligence and Smart Environments. Furthermore, she is involved in several (inter)national third party funded research projects and supervises several PhD projects.

Veysel is a Senior Data Scientist and Healthcare NLP Lead at John Snow Labs, improving the Spark NLP for the Healthcare library and delivering hands-on projects in Healthcare and Life Science. 

He is a seasoned data scientist with a strong background in every aspect of data science including machine learning, artificial intelligence, and big data with over ten years of experience. He’s also pursuing his Ph.D. in ML at Leiden University, Netherlands, and delivers graduate-level lectures in ML and Distributed Data Processing. He is also working towards his PhD in Computer Science and is a Google Developer Expert in Machine Learning.

Veysel has broad consulting experience in Statistics, Data Science, Software Architecture, DevOps, Machine Learning, and AI to several start-ups, boot camps, and companies around the globe. He also speaks at Data Science & AI events, conferences and workshops, and has delivered more than 20 talks at International as well as national conferences and meetups.

Mostafa has been active in the field of AI for the last 18 years, working on a wide range of topics namely NLP, computer vision, speech recognition, automation, and robotics. He is a PhD graduate from EPFL and has been a Tech Lead for conversational AI at Swisscom. He is an Engagement Director and Data Scientist at Unit8 working actively on the topics around Azure and OpenAI services.

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and is responsible for Innovation within Deloitte Switzerland’s Executive team. His team helps clients leverage the power of artificial intelligence and data to deliver more customer-centric and innovative products and services that catalyse growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global transformations, leveraging new delivery models (GBS/SSC, outsourcing) and innovative technologies (e.g. robotics, machine learning, natural language processing/generation). He helps global organisations review and implement new strategies for business support functions and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

Maxine leads the Diverse Data initiative at Genomics England, which aims to reduce health inequalities in genomic medicine by ensuring patients, regardless of their background, receive the same quality of genomics-enabled personalised medicine, supported by the latest research on people like them. Maxine is also the co-founder of One HealthTech – a global, volunteer-led, grassroots community that supports and promotes under-represented groups in health innovation. She also set up Data Science for Health Equity, a community of practice that brings together those with expertise in data science and health inequalities to connect and collaborate on cutting-edge domains in health. She has been part of a number of communities and committees including being a Non-Executive Director for the Eastern Academic Health Science Network, a member of the World Economic Forum’s Global Shapers, and the British Computer Society (Health Exec) and the DeepMind Health Independent Review Board.

Bethel Dereje is a Gynecologic Oncologist and an assistant professor of Obstetrics and Gynecology at St. Paul’s Hospital Millennium Medical College. Dr. Bethel is also the Founder and CEO of Wecare Digital Health which managed to take the largest market share of Digital Health service in Ethiopia. 

She has served as a lecturer, undergraduate program coordinator and as an assistant Dean of St. Paul’s Hospital Millennium Medical College. She was one of the female physicians to realize Ethiopian Medical Women Association (EMeWA) and served as Executive board member for the first year. She is also an active member of Ethiopian Society of Obstetrics and Gynecology (ESOG) and Ethiopian Medical Association (EMA).

Apart from her professional activities she delivers her social responsibilities in teaching high school students, leading outreach programs for orphanages and as a board member of Addis Ababa city administration school feeding program. 

Dr. Bethel is a proud wife and a mother of four. She is passionate about MENTORSHIP and gender EQUITY. As a hobby she enjoys gardening.

Nicole Spieker is a healthcare professional with 17 years on the ground experience in Africa. A scientist by training, she has focused her career on developing and scaling innovative models for change that drive inclusive quality healthcare, especially for vulnerable groups.

She is the CEO of PharmAccess, an international not-for-profit organization dedicated to strengthening health systems in sub-Saharan Africa. PharmAccess’ mission is to create access to affordable, quality healthcare for low-income groups. This is achieved through the introduction of standards, the creation of health insurance systems, and provision of affordable loans to private clinics. Mobile and digital technology are considered key transformational elements in achieving UHC. At the core is the M-TIBA mobile health wallet, which connects patients, payers and providers. M-TIBA creates new digital solidarity mechanisms where people start paying for each other, and efficiently channels funding to target groups at very low transaction costs.

Dr Spieker is also the founder of SafeCare, an internationally accredited (ISQua) standards-based methodology that healthcare facilities use to improve their quality-of-care. SafeCare has been adopted by public and private partners in over 15 African countries.

Previously, Dr Spieker was Director of clinical support services at the Aga Khan Health Services, Dar es Salaam, Tanzania and assistant professor at Aga Khan University. She holds a PhD in Molecular Genetics of the University of Amsterdam, The Netherlands.

Pau Rue is an accomplished data and AI/maching learning leader with a track-record of building impactful ML and Data Science and AI solutions in different industries. He currently services as the VP of AI for Infermedica, a Poland-based digital health company specializing in AI-powered solutions for preliminary diagnosis and patient triage. After having earned a PhD in Computational Physics and a short career in Academia (University of Cambridge), Rue transitioned to the industry, first as a Staff Data Scientist (Schibsted/Adevinta), then as a Data and ML team leader (Telefonica Alpha Health) and executive (Typeform), before joining Infermedica.

Hanno Ronte is a Partner at Monitor Deloitte, in Deloitte UK’s strategy consultancy business. He has more than 20 years of consulting experience primarily in the Healthcare and Life Sciences sector. Hanno leads the Life Sciences and Healthcare team in Monitor Deloitte and is responsible for building the Real World Evidence Capability within that. His projects focus on corporate and business unit strategy, competitive response, marketing strategy and capability building

Berit is a Director in Deloitte’s AI & Data Consulting practice, based out of Zurich, Switzerland. She focuses on enabling value from data for our Life Sciences and Health Care clients and is the Program Manager of Deloitte Switzerland’s Generative AI working group.

Berit’s sweet spot is where AI and strategy meet. A data scientist by training, she started out in industry as a strategy manager at an international pharma group before finding her passion for consulting.

Berit is a seasoned project manager, focusing on innovative, pragmatic solutions using agile methodology: She has led data teams of up to 15 members, delivering complex global projects on time and on budget. She is an engaging facilitator, well-versed at running data and AI strategy workshops using methodologies such as design thinking, lean start-up and Deloitte Insight Driven Organisation framework. 

Berit holds a Ph.D. in Economics and Finance from University of St. Gallen (HSG), focused on health econometric applications and which she finished during a 1-year research fellowship at Harvard University.

Matt Arentz is a pulmonary physician and data scientist with 15 years of expertise in TB diagnosis and treatment, including 10 years of tuberculosis research in East Africa and 5 years working on global disease burdens and health technology. He spent 10 years in academic medicine at the University of Washington and its affiliates while conducting clinical research on tuberculosis in East Africa and mycobacterial research in the United States. Doctor Arentz also has expertise in data science and has an MPH in global health metrics from the University of Washington. While working with the Institute of Health Metrics and Evaluation, he modelled the impact of the COVID-19 pandemic on TB global case finding.  Additionally, Dr. Arentz worked as a visiting scientist at Microsoft from 2020 to 2021 where he helped develop their global health access program.  Beginning in 2021 Dr. Arentz joined FIND as a senior technical consultant. Matt leads FIND’s validation platform, which focuses on evaluation of AI based diagnostics.

Reto Häni is a Cyber Risk Services Partner at Deloitte Switzerland. He leads the Cloud Security and Risk practice for Risk Advisory across Europe, is member of the European Cloud Transformation Leadership, acts as the global relationship responsible for Saviynt and delivers innovative security solutions and performs large-scale transformation programs across the whole Cybersecurity portfolio. Amongst other roles, he previously worked as the Cybersecurity leader at another Big 4, as the group CIO at the Swiss Department of Defense and Chief Security Advisor at Microsoft responsible for Western Europe. 

Reto has over 20 years of experience in Information Security and Risk focused ICT environments. He has deep experience in Information and Telecommunication Security focusing on IT strategy and governance, Cloud Security, Cybersecurity, Infrastructure Security, Risk Management, Business Continuity Management, Data Protectio and Identity & Access Management. Reto proved his leadership experience in commercial and public sector at local, regional and global level.

Paul is a Swiss qualified attorney-at-law and Partner of Deloitte Legal Switzerland. He has more than 15 years of experience as a business lawyer, notably in M&A and Digital Law, and is very active in governance and Board of Directors assistance. Prior to joining Deloitte in 2017, Paul worked for an international and one of the largest law firms and a big 4 in Switzerland. Paul is the Chairman of his own Family Business and member of the Family Business Network Switzerland and International located in the IMD offices in Lausanne. 

Peace Ndoli Iraguha is a visionary healthcare provider and entrepreneur, holding a bachelor’s degree in human nutrition and Dietetics, along with a master’s degree in Global Health Delivery. With a passion for enhancing lives, Peace’s journey began as a dedicated nutritionist in both public and private healthcare sectors. These experiences paved the way for her transformative entrepreneurial venture as a co-founder of Lifesten Health.

Her dynamic leadership steered Lifesten Health to a remarkable milestone, clinching the prestigious 2022 Innovator of the Year award in Rwanda. Additionally, her continuous contribution to Lifesten Health led the company to secure victory at the Kigali Cardiovascular Challenge. Under Peace’s guidance, Lifesten Health pioneered incentive-driven health and wellness programs, contributing to transforming lifestyles.

Her exceptional ability to cultivate partnerships and networks, strategically positioned Lifesten Health to address the escalating Non-Communicable Disease challenge in sub-Saharan Africa. Peace Ndoli Iraguha embodies a relentless pursuit of a healthier, more vibrant future for all.

Andrea is an electronic engineer (BSc) and biomedical engineer (MSc) with a PhD from the École Polytechnique Fédérale de Lausanne (EPFL) for his research activity in Neurotechnology for Brain-Repair and Brain-Computer Interfaces. He is the CEO of confinis ag, a Swiss regulatory consulting firm specialized in regulated innovation. In the past, he designed and managed randomized controlled trials and authored several scientific publications and few patents related to AI and machine learning in healthcare. Andrea has in-depth knowledge in Biostatistics, Machine Learning, Signal Processing, and Data Analysis. He created two neurotech companies, Intento SA and braincredible SA. Intento was acquired in 2018 by mindmaze group; braincredible – a spinoff of ANT Neuro – currently sells solutions to collect big EEG data. Andrea holds an honorary appointment as President of the Basel Chapter of the Italian Chamber of Commerce for Switzerland (CCIS).

Over the past two decades, I have had the privilege to work with the largest organizations in the life-science industry, including Novartis, Philips Medical, Novo Nordisk, Leo Pharma, and some of the biggest consulting-firms in the world.

During this time, I noticed that most established organisations use large and expensive solutions and consultants for operations and projects. And with expensive solutions come, expensive consultants, including myself, to navigate the complex regulatory landscape within life sciences — compliance could be an actual show-stopper for small and mid-sized MedTech and Life Science companies.

To me a solution had to be found — I had to do something and change that. I created MyBlueLabel to revolutionize compliance and with a keen focus to make compliance a business advantage for all companies. 

With the knowledge of how to get regulatory approval, I designed a digital platform with a work-break-down structure to help MedTech companies swiftly incorporate a compliance framework into their company, allowing them to become and stay compliant at a fraction of the expense and difficulty.

Nishant Sinha is a Director in AI and Data Strategy. He specializes in Artificial Intelligence, Automation, Machine Learning and Analytics Strategy. Nishant leverages his 20+ years of experience in Life Sciences consulting to support his clients successfully embark on data driven transformations, bringing a customer centric approach to the business process and model redesign enabled by Artificial Intelligence

Lisa Falco, PhD, is Lead Consultant for AI & Data at Zühlke. She has 15+ years of industry experience in in machine learning for healthcare and has led the development of two AI based medical device products, that were brough to market under regulatory requirements. She combines a solid know-how in machine learning and AI with wearables, medical imaging and a passion for building user centric products, especially within the domain of healthcare and MedTech. She is the author of “Go Figure! The astonishing science of the female body”, a regular Forbes contributor and an advocate for women’s health, active in the FemTech community.

Benjamin von Deschwanden is driven by the belief that cutting-edge Document AI technologies have the potential to revolutionize how businesses handle information, streamline workflows, and enhance decision-making processes. 

With a background in Computer Science and as a Teaching Assistant at ETH Zurich, Benjamin co-founded Acodis back in 2016 with the mission to turn any document into value.  

In his current role as Chief Product Officer, he is spearheading the development of groundbreaking products that redefine the way we interact with documents, transforming the future of document processing as we know it. As such, three out of the top ten pharma and health companies worldwide are relying on the Acodis platform to structure and extract data from documents.

Wolfram von Ehren leads the Business Operations Team for Life Science, a group focused around creating efficiency and effectiveness of pharma and med-tech organizations enabled by organizational, process-driven and digitalization transformation.

His experience from 25+ years in Deloitte Consulting stretches from strategic assessments all the way to running major international transformation programmes. He is particularly strong in transforming strategy into executable programmes, by building a business perspective on processes and technology enablement. He has a solid background in major platforms such as SAP or Salesforce, and enjoys exploring new possibilities alongside proven tools.

His ambition is it to leverage digitalization and AI in cross-functional processes, connecting people and data for higher productivity.

Meet Wim Kees, Founder and CEO of Syntho, a startup that is disrupting the healthcare sector with software for AI-generated synthetic data to unlock privacy sensitive data and shorten the time-to-data. Why? The potential and pressure to innovate with data in healthcare is enormous. However, healthcare data is the most privacy sensitive data and is therefore locked. This privacy sensitive data is time-consuming to access, requires extensive paperwork and cannot simply be used. Hence, Syntho is on a mission to unlock this data to make sure that data-driven innovation will be realized. Wim has proven with Syntho that he can make (privacy-sensitive) data more accessible and quickly available for leading healthcare organizations such as hospitals, pharmaceuticals, healthtech and life science organizations, to make sure that those organizations can realize data-driven innovation. Wim Kees and Syntho won the prestigious Philips Innovation Award, won the Global SAS Hackathon in Healthcare & Life Science, and were shortlisted as Generative AI startup “to watch” by NVIDIA. So, why use real data when you could use synthetic data?

Frank is a Director in Deloitte’s AI & Data Consulting Practice in Switzerland.  Frank’s focus and commitment is bridging his life sciences clients’ business strategy needs to analytics & new technology to provide value/competitive advantage.

Frank is innovative, and structured and speaks business and digital fluently – a trusted advisor with significant management experience. High level of analytical and leadership skills. Strong communicator and inspires teams and clients in what he does. Global citizen and works well in all cultures at all levels.  

Frank is also an SME on Digital Health solutions and their development and commercialization, engaged with key Life Science companies and consortia, while also contributing to Intelligent Health conferences and lecturing on Digital Health at Universities. 

His mother tongue is Danish and he is fluent in English and German.

In 2015, Sanath Kumar, a 19-year-old college dropout with a trove of patents and the distinction of the National Innovator Award, initiated his venture into the dynamic world of technology. His entrepreneurial drive was propelled by a singular vision: to serve the Humans of Smitch. Starting with a simple light bulb integrated with India’s first chip-to-cloud IoT stack, Smitch quickly permeated 700,000 households.

Yet for Sanath, this was just the groundwork. The essence of Sanath’s leadership lay not just in scaling but in recognising broader horizons. Delving deep into the data lake formed by Smitch’s smart home products, Sanath deciphered the shifting consumer behaviours. This data-driven insight prompted a pivotal shift: transitioning from mere volume to creating profound value. This evolution birthed the “Human Token,” a revolutionary concept bridging technology with preventive healthcare, a significant departure from Smitch’s original offerings.

To manifest this vision, Sanath has meticulously built a team comprising some of India’s best minds, ensuring Smitch is not only at the forefront of technology but also embodies a collective drive for genuine healthcare evolution.

Founder & CEO of Render Health Technology, with many years of experience in the biotech and healthcare industry. He has worked in several hospitals across the United States of America supporting breakthrough clinical trials in oncology and infectious diseases. He is committed to bringing simple Healthcare solutions to the people and places that need it the most.

Yurii Kryvoborodov is an experienced Product Manager with a remarkable background in delivering and growing products through their entire life cycle. With over 10 years of experience, Yurii is known for his result-oriented, data-driven, and proactive approach to management. He is a SAFe certified product manager, equipped with exceptional multi-cultural communication skills, enabling him to effectively manage diverse projects with clients from the US, EU, UK, Israel, China, and Latin America.

Currently serving as the Head of Technology Consulting at Unicsoft, a Global Software Solutions Vendor, Yurii is playing a key role in defining the product vision and strategy, developing the business model, and designing technical architecture for businesses around the globe. In addition to AI for the healthcare industry, his main areas of expertise are fintech and blockchain.

Yurii has an impressive track record of improving business profitability, implementing modern delivery methodologies, ML models, and optimizing operational pipelines. He has successfully launched high-load platforms in various business domains, increased product conversions, and integrated third-party systems to improve customer retention.

Yurii holds a Master’s degree in Finance and Banking and a Master’s degree in Jurisprudence. He has a wide range of certifications, including Stanford Machine Learning Certificate, SAFe Product Owner/Product Manager, QAI Certified Software Business Analyst, and Agile Certified Professional, among others.”

Dr Zaid Al-fagih is the Co-Founder and CEO of Rhazes AI. He is a medical doctor who has worked in challenging healthcare environments, including warzones. He is also a previous health tech founder and has worked in cross-disciplinary research on applying technology to solve problems in healthcare. He also holds a Master of Public Policy from the University of Oxford’s Blavatnik School of Government and a BSc in Management from Imperial College Business School.

Sharon Batamuriza works at Bridge for Billions as Senior Program Manager for HealthTech Hub Africa. Sharon is an innovative technology solutions and logistics leader, helping to bring market expansion to Africa and beyond. Her investment, supply chain, and start-up development expertise has been proven in her work with global enterprise platform Kountable and as a Consultant for the FintechHub Rwanda and Euro Exim Bank. A Bennington College graduate with a bachelor’s degree in Political Economy and Conflict Resolution, Sharon is fluent in English, Swahili, and Kinyarwanda.

Dr Chris McKee is Managing Director for Better Medicine. As Better Medicine expands to international markets, his focus is to foster collaboration with a diverse range of stakeholders, including startups, academic institutions and healthcare providers.

Chris is passionate about driving transformative change in the field of health and life sciences through innovation. With a deep understanding of the industry and a keen eye for emerging trends, he specialises in business development for innovations that revolutionise patient care and improve overall well-being. 

As a seasoned professional in health and life science innovation, he has successfully led cross-functional teams to implement cutting-edge technologies, digital solutions, and novel therapies. His expertise lies in leveraging data-driven insights, artificial intelligence and a range of digital health solutions to unlock new possibilities in healthcare delivery, precision medicine, and biomedical research. 

Chris has collaborated with industry leaders, researchers, and clinicians over the years to identify unmet needs and translate them into impactful strategies and products, skills which he now gladly contributes to Better Medicine. 

By bridging the gap between scientific breakthroughs and practical implementation, Chris strives to bring breakthrough technologies to market, transforming healthcare systems and positively impacting lives on a global scale.

Dr William Mapham founded Vula to connect health worker professionals. His first-hand experience as the Vice-Chair of the Rural Doctors Association and as a specialist ophthalmologist helped form the solution. He has published academic articles on the role of innovation and technology in improving healthcare delivery. To date, Vula has 32,776 registered health workers on the platform and 1,359,398 patients have benefitted to date. William believes that partnerships are the key to delivering healthcare. Vula has partnerships with academic institutions, public sector departments of health and pharmaceutical companies.

Sami Chagar is a dedicated entrepreneur with a passion for transforming medical education. As a co-founder of Docthus, he envisions a world where medical professionals across Africa can access cutting-edge knowledge and techniques effortlessly. With a background in IT, Sami recognized the pressing need for a comprehensive platform that connects doctors, provides live surgeries, and facilitates expert collaboration. Docthus, under Samil’s leadership, has emerged as a pioneering solution that bridges the gap in medical learning by offering real-time access to surgical procedures, interactive webinars, and expert guidance. Sami’s unwavering commitment to enhancing medical knowledge and patient care has positioned Docthus as a transformative force in healthcare education, empowering doctors to excel in their practice and save lives.

Dr. Robert Korom is a board-certified internal medicine physician. Dr. Korom earned his medical degree from Weill Cornell Medical College in New York City, USA, and completed his medical training at Massachusetts General Hospital in Boston, where he was a clinical fellow at Harvard Medical School. Dr. Korom has published several peer-reviewed studies of Penda’s work in clinical quality improvement. He works closely with Penda’s digital health and technology teams to improve clinical decision making and enhance patient experience.

Conrad Tankou is a medical doctor from Cameroon, a technology enthusiast who passionately believes that most of the health challenges in Africa can be solved through technology solutions which are adapted to the African context. He founded GIC Space, a health tech venture which designs and promotes cutting edge and cost-effective solutions for health challenges in Sub-Saharan Africa. Its flagship product is called GICMED, which targets breast and cervical cancers through a panoply of proprietary health tech solutions, with several recognitions received so far for its achievements. With his experience so far in technology, medical practice, and entrepreneurship, he hopes to be a pillar in ensuring that even the most remote communities in Africa enjoy standard and affordable healthcare.

Dr. Joseph Olowe, CEO, has over 30 years in allied health and business. He has built and sold many businesses and has been in the wellness industry for more than 20 years. Joseph leads our product development and execution. He can rightly be described as an epitome of virtue, with great accomplishment in business. He’s a graduate of the University of Lagos (BSc) in Physical Therapy, Rocky Mountain of Health Professional (MSc in Health Sciences and Doctorate in Physical Therapy), and University of Phoenix (MBA), currently the CEO of Omega Health Systems and sits on many boards. Joseph has exited two startups with resounding successes and loves to do charity work (he is currently the Volunteer CEO of His Dominion Christian Organization). He’s currently the only provider of a hi-tech health and wellness platform driving preventive care in Nigeria and is looking forward to growing into other Sub-Sahara African communities.

Kidist is a dynamic and accomplished strategic leader with over 12 years of experience in top-tier management and administrative positions spanning diverse sectors such as finance, education, business, and healthcare. She holds a Master’s in Specialized Studies in Medical Education Curricula and Entrepreneurship from Harvard University with a focus on Africa, and a Bachelor’s of Individualized Studies from the University of Minnesota in Global Studies, Strategic Communications, Public Health, and a Minor in Spanish.

Born in Ethiopia and returning after college, Kidist is dedicated to driving Africa’s growth through her vision of establishing a leading women’s healthcare brand. A visionary leader, she is passionate about leveraging her skills to create a positive impact globally. Committed to empowering African women in reproductive health, her revolutionary startup is reshaping women’s healthcare across the continent. With a background in strategic operations, design thinking, and venture building, Kidist excels in leading teams towards growth.

A former Director of Innovative Strategies and Operations at a prominent government hospital and medical college, Kidist’s expertise extends to advising the Minister of Health. She co-directed Harvard Innovation for Ventures in Education, mentoring student entrepreneurs. An advocate for volunteerism, she mentors young entrepreneurs and believes innovation, education, social impact, and youth drive African economic development. Kidist’s groundbreaking women’s health-tech startup, YeneHealth, embodies this commitment.

Beyond her professional achievements, Kidist enjoys travel and solving complex problems. Her exceptional academic credentials, industry experience, and relentless pursuit of her aspirations reflect her strong work ethic and underscore her Ikigai.

Naom Monari is a Visionary social entrepreneur and founder of Bena Care, a social enterprise based in Kenya. Recognizing the profound economic and emotional toll of long-term hospital stays, Naom established Bena Care with a mission to revolutionize healthcare systems, particularly those that perpetuate extreme poverty and enhance the well-being of chronically ill patients in Kenya. By leveraging the extensive healthcare professionals’ network; she has developed a unique healthcare model that addresses the multifaceted barriers to effective healthcare delivery while spearheading a paradigm shift in healthcare accessibility and ultimately improving healthcare outcomes for the communities.

Jelle Schuitemaker is one of the founders of GOAL 3 with the mission to make quality healthcare fair and accessible for everyone, by focusing on smart, AI and data-driven technologies suited for low resource settings. Through the GOAL 3 IMPALA system, GOAL 3 enabled and empowers healthworkers to save lives, time, and costs in overburdened settings across Africa. 

Jelle is an out-of-the-box thinking, young and creative entrepreneur, marketeer, innovation- and business manager, specialized in the combination of Technology, Marketing, Innovation and Start-ups with a strong mission for a better world through using innovation and technology as a force that can make a positive change in the world.

Elizabeth is an avid entrepreneur with a pharmacy and business education background who has over 17 years’ experience building businesses in the UK and Africa.  She successfully set up and grew her own brand pharmaceutical wholesale business from one to seven Sub-Saharan African countries with several high quality ethical and OTC products in various markets before exiting in 2016 to launch Wazima Health.  She is passionate about health and improving the access to and delivery of quality healthcare services. Her work in the healthcare space includes various projects in the UK’s NHS and with the UN and WHO in Sub-Saharan Africa. As a speaker, she regularly shares her expertise on various health and technology related platforms globally including Europe, Africa and UAE.

Dr. Jerome Nshimiyimana is the Founder and CEO of Jo Grp Ltd, the driving force behind the innovative healthtech platform JoCare. As a medical doctor working under the Ministry of Health, his journey in healthcare has been fueled by a deep commitment to improving lives.

During his time studying medicine at the University of Rwanda, Jerome realized the urgent need for accessible and accurate health information across various areas. This led him to create JoCare, a platform that provides evidence-based information and services, not only in sexual and reproductive health but also in telemedicine, non-communicable disease prevention, and inclusion of people with disabilities.

From its inception, JoCare has grown beyond his expectations, impacting thousands of lives and even conducting crucial research. Jerome’s commitment to innovation, inclusivity, and community welfare has gained recognition and support from organizations like Imbuto foundation, HealthTech Hub Africa, UNFPA, Save the children Rwanda and Westerwelle Foundation.

Together with his dedicated team, Jerome is striving to create a world where everyone has access to vital health information, services, and the opportunity to lead healthier lives.

Fabian Scheugenpflug is a trained medical physicist and leads the venture’s activities for Plug and Play Health EMEA. He has been the first team member of Plug and Play’s joint Venture with Roche Diagnostics – Startup Creasphere, a digital health innovation framework.

As part of his role, Fabian works with a multitude of Fortune 500 companies on specific projects ranging from enhanced POC capabilities to improving access to healthcare in the global south. Since the inception of Startup Creasphere Fabian has been leading more than 90 pilots. Additionally, he played a vital role in the expansion of Startup Creasphere to Asia and America. Besides his corporate engagement, Fabian has executed investments into 12 early-stage digital health startups which truly transform the perception of future healthcare. Some of his prominent portfolio firms include TestCard, Hyfe and Dyad.

Luca Emili is an entrepreneur and investor, Founder and current CEO of InSilicoTrials Technologies, a pioneering platform that leverages modeling and simulation to accelerate innovation in healthcare and life sciences.

From 2001 to 2010 he was CEO of Emaze, a cybersecurity company that became one of the market leaders in Italy by automating security analysis for complex networks and devices. He is member of the Cloud Security Consultative Group in EMA and is responsible for the RCA Research Collaboration Agreement between InSilicoTrials and the FDA. He also co-chairs the Good Simulation Practice Task Force within the Avicenna Alliance’s Policy Development Working Group, with the goal of driving a consensus approach toward standardization for reliable development and use of in silico solutions.

Vasileios is Co-Founder and Chief Operating Officer of Aisthesis Medical. His background is on Electrical and Computer Engineering with a major in Biomedical Engineering. Currently he completes his PhD at ETH and University of Zurich where he performs research on Computational Neuroscience. One of his biggest achievements was that he was selected in the Forbes 30 under 30 in 2022 thanks to the contributions of Aisthesis Medical in the healthcare sector. His industrial experience involves working at big corporates and research institutes including IBM and CERN. Driven by his passion for innovation he envisions revolutionizing the healthcare sector by introducing Aisthesis Medical into the wide market of predictive analytics for clinical decision support.

Janis is Chief Medical Officer at AICURA medical. Prior to joining AICURA, he pursued his PhD at the Max Planck Institute for Human Cognitive and Brain Sciences, where he specialized in brain imaging and examined the effects of stress on brain plasticity. Simultaneously, he gained practical experience as a part-time psychiatric physician. Recognizing the substantial gap between cutting-edge, data-driven research and the outdated technology commonly found in clinical settings, Janis was inspired to transition to AICURA to work on using data science and AI to enhance clinical research and healthcare delivery.

Electrical Engineer (Master Degree, Ruhr Universität Bochum) with programming experience since 1987.

Project experience around Europe since 2000. Investor in Nextnetinc.com 075%

Kathrin Biernat is CEO of 123 Sonography GmbH, a global leader in online medical education in the field of ultrasound and echocardiography, with more than 400.000 customers and users worldwide.

She has a profound background in Digital transformation in Strategic Marketing, Sales, and Business Development, with more than 13 years of international experience. Kathrin started her career in Sales and Strategic Marketing in a medium-sized lighting company, completing her first University degree in English and combined European studies at the Karl-Franzen Universität in Graz in 2008. After completing her MBA studies in 2012, she spent several years in the global headquarters of a German enterprise in Munich in Strategic Planning and Digital transformation in Business Development, Sales, and Marketing and returned to Austria in 2020

Shubha is a seasoned leader with over 24 years of experience in Healthcare Strategy, Digital Transformation, and Clinical Data Operations. She possesses a strong risk and quality mindset, leading with solutions that yield the best value outcomes. Shubha is adept at cultivating cross-functional relationships to drive strategic operations.

Mayoro Diagne is a 43-year-old accomplished Software Engineer living in Dakar, with 17 years of experience in the tech industry. A proud graduate of Ecole Superieure Polytechnique de Dakar (ESP), he has a passion for martial arts, innovation, and AI. Throughout his career, Mayoro has held numerous responsible positions in both public and private sectors, ranging from small to large companies.

Currently serving as the COO of Baamtu Technologies, Mayoro brings his extensive knowledge and skills in engineering and IT to every project he oversees. His expertise in project management is further reinforced by his ITIL® v3 and COBIT® 5 certifications. Mayoro’s strong academic background in computer engineering has enabled him to excel in various roles within the tech industry.

As the former Technical Director at Makeba, a fintech company, he designed and implemented a mobile money platform. During his tenure at ADIE, the Senegalese IT Agency, Mayoro held various positions and made significant contributions to numerous e-government initiatives. In his current role at Baamtu, he has successfully audited tech startups and led crucial projects for both private and public sector clients.

Mayoro’s diverse experience highlights his ability to manage large-scale projects, adapt to new technologies, and develop innovative solutions that benefit organizations across industries.

Christoffer Ekström is one of the founders of AI Medical Technology and is the company’s CEO and one of the board members. He is a serial entrepreneur and holds a Master’s degree in immersive technologies (M.Sc.) from Stockholm University and finalising a bachelor’s degree in business administration (BBA) at Uppsala University. Christoffer is an experienced climber and adventurer.

Dario has a PhD in Neuroscience from the International School of Advanced Studies in Trieste, Italy.  He has over 15 years of experience in pre-clinical and clinical research in academic and private organizations in Italy, France, and the United States. He dedicated the last 7 years of his life to digital health and digital medical devices, focusing on supporting product teams in delivering effective, beneficial, and impactful digital solutions to patients and care teams worldwide. First by leading a team of Software Developers and Data Scientists at Vistronix (US) and for the past 5 years at Roche where he focused on Clinical Evidence and Clinical/Performance Evaluation. His experience, though, spans all aspects of digital health solutions: Over the years, he participated in and led the development and validation of a diverse range of regulated digital products including Digital Endpoints, Digital Therapeutics (DTx), Remote Patients Monitoring solutions (RPMs), Clinical Decision Support tools and algorithms.

Carl Leitner, Ph.D.  is a Technical Officer with the World Health Organization, Geneva. He is the former Technical Director of Digital Square at PATH and Associate Director of Health Workforce Informatics at IntraHealth. Carl Leitner brings more than twenty years of experience in informatics, information technology, software development, and education including more than fourteen years of designing and adapting health information systems in low- and middle-income countries.   Leitner has worked closely, in a variety of roles, with many digital health global goods. Leitner also regularly engages with health informatics standards development organization and has co-authored several health informatics standards. Leitner has led numerous workshops working with in-country teams to build their capacity to implement and manage interoperable health information systems and to make use of data for effective decisions and policymaking.

Nicholas Kelley is the Director Data Science & A.I. Portfolio Strategy and Innovation in the central Novartis Data & AI organization, and has two main priorities.  First, to identify, prioritise, and launch key use-cases with the mission of delivering reusable AI capabilities for the scientific and medical core of the business.  Second, to better define the AI opportunities landscape and needed capabilities across the value chain.  Here the key focus is on continued improvement of our Novartis data science foundation through innovative partnerships and by leading the data science community and capability building initiatives.

Recent initiatives include seeding and driving AI solutions such as Generative Chemistry as part of the partnership with Microsoft Research, the first cross-Novartis Data Science challenge in collaboration with MIT, and launching the AI for Life Residency program.

Nick has a formal background in computational methodology with a Ph.D. in Biophysics from Stanford University, with career experience in computational biology, chem- and bioinformatics, and most recently in the application of A.I. and machine learning in health.  

Since 2014, Dr. iur., LLM, Lukas Engelberger is a member of the Government of the Canton Basel-Stadt and Head of the Public Health Department. 

He is also President of the Swiss Conference of the Cantonal Ministers of Public Health (GDK) and Member of the Board of Swissmedic (Swiss Agency for Therapeutic Products). He also is Member of the Board of Cantosana AG.

After his studies in law at the universities of Basel, Fribourg and Bern, he obtained the bar examination (Canton of Basel-Stadt) in 2001. In 2003 he doctorate in law at the university of Basel and holds a LLM (University College London). 

From 2003-2005 he was practising as an atorney at Bär & Karrer in Zürich (Practice areas: M&A, capital markets, general corporate and commercial matters). From 2005- 2014 Mr. Engelberger was a legal counsel at F.Hoffmann-La Roche Ltd. in Basel.

Elena Bonfiglioli is Microsoft’s Global Business Leader for Healthcare and Strategy Lead for Pharma Life Sciences. 

In this capacity she is responsible for industry pharma strategy and commercial go-to-market, enabling co-innovation and engagement with strategic customers and partners to accelerate their transformation with cloud and AI.  

She was recently elected as Vice Chair of the DIGITALEUROPE Executive Council for Healthcare. 

A signature outcome of her work – together with a core team across engineering and research – was the design and launch of the AI partnership with Novartis in 2019 and the AI for Leprosy initiative with Novartis Foundation and Fiocruz, recently published in The Lancet/Elsevier.  

Elena co-chaired the Health Cloud Council for Microsoft and partners from 2015-2019 where she led the development of a position on secondary use of health data and championed the work on data collaboratives, leading to the creation of the first global data collaborative in cardiovascular population health.

Elena has been working in the health sector for 18+ years, first in health policy at EU level and then as regional business leader in public healthcare across EMEA. In July 2017, Elena was elected to the HIMSS Europe Governing Council.  In 2020 she was nominated one of the top 50 AI Innovators by Intelligent Health.  Elena is one of the founding members of the Holomedicine Association.

She is an active advocate and public speaker, invited to represent the approach of Microsoft for Healthcare and AI and how Data save Lives.  She is also a champion for the transformational impact of meditation in personal and professional development, working with the Centre for Evolutionary Learning; and the empowerment of women in leadership. 

Recent articles:

• (99+) Empowering change: how mixed reality is driving the future of medicine | LinkedIn
• Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health | Novartis Foundation
• Harnessing health data for better outcomes: a call to action – Microsoft Industry Blogs
• Improving the pace of vaccine distribution through technology – Microsoft Industry Blogs

Vicky Levy is the Deloitte Global Life Sciences sector leader. In this role, she ensures our leaders around the world are able to bring the best of Deloitte to bear in the life sciences sector, helps to build the global capabilities of Deloitte in the sector and guides and advises Deloitte Life Sciences leaders across our global network as they serve global clients. Vicky brings more than 25 years of global life sciences professional services experience to our clients around the globe. She advises executives across a range of topics, including executive transitions, enterprise transformation, commercial performance, culture and diversity, equity, and inclusion.

Dr. Yaron Ilan is the Director of the Department of Medicine at the Hebrew University-Hadassah Medical Center. Dr. Ilan served as the Vice Dean of the Hebrew University-Hadassah Medical School. Dr. Ilan was a Visiting Professor at Harvard University, working on novel immunotherapies. Dr. Ilan’s main areas of research are developing artificial intelligence-based algorithms for improving care, developing immunomodulatory therapies for fatty liver disease, diabetes, and inflammatory bowel diseases, and developing drugs for primary liver cancer. Dr. Ilan holds over 50 patents for discoveries based on his innovative research and has authored more than 300 articles. He is the inventor of several drugs and medical devices developed by several pharmaceutical companies. Several of his innovations have already reached the clinical market. Dr. Ilan is the founder of several companies and is a medical director and advisor for several biotech companies.

A board-certified internist, Daniel Knecht, M.D., currently serves as Vice President, Chief Clinical Innovation Officer, CVS Caremark. Dr. Knecht’s focus is on helping clients better understand the evolving clinical landscape of specialty medications, develop strategies for better patient care and outcomes, and manage costs. 

Prior to this role, as Vice President, Clinical Product, Dr. Knecht was responsible for clinical product ideation, concept development and testing, optimization, launch, performance, and measurement in collaboration with key stakeholders across the enterprise.

Dr. Knecht is a Fulbright scholar and graduated with honors from Dartmouth College. He also has a joint M.D., M.B.A., from Weill Cornell Medical College and Johnson Graduate School of Management where he was a recipient of the Lee Family Scholarship. He is an associate clinical professor at Mount Sinai West in New York City where he still sees patients, and a member of the Board of the Foundation of CUNY School of Public Health.

Dr Stefan Germann is the CEO of Fondation Botnar, a Swiss-based foundation which champions the use of AI and digital technology to improve the wellbeing of young people in urban environments. To achieve this, the foundation supports research, catalyses diverse partners, and invests in scalable solutions around the world.

Dr Germann has spent over 25 years working in various leadership roles in Africa and Asia, focusing on health-related development for children, relief and advocacy work. He was previously the Senior Director of World Vision’s International Sustainable Health Partnership, Innovation and Accountability unit based in Malaysia. His work focused on a complex relief and reconstruction program in response to the Asian Tsunami. 

He has previously held several board and advisory board memberships. These include for the Partnership for Maternal, Newborn and Child Health (PMNCH), UBS Optimus Foundation, REPSSI in Africa, the Global Health Program and The Graduate Institute in Geneva, where he focused on the role of NGOs in global health diplomacy.

Dr Imran Siddiqui studied in London and trained in clinical radiology in the NHS, prior to joining Bayer, where he now leads the Radiology Medical Affairs team for the UK. He focuses on growing value and expertise for both pharmaceutical and medical device products, advising on medical and commercial strategy and driving regulatory excellence and innovation. Imran is passionate about medical education as well as the safe and sustainable adoption of AI technologies. He was a core team member for the global launch of an AI platform technology for medical imaging, was recently awarded a scholarship to complete the renowned UCL ‘Artificial Intelligence in Business’ executive course on AI implementation and strategic business models and sits on the British Institute of Radiology’s AI & Innovation specialist interest group.

Dr. Jim Ritchie is the Chief Clinical Information Officer and Deputy Director for Research and Innovation (Digital Health and Artificial Intelligence) at the Northern Care Alliance and an Honorary Clinical Lecturer at the University of Manchester. He continues to practice clinical medicine as nephrologist Salford Royal, one of the most digitally mature trusts in the NHS.

Jim supported delivery of the Salford Global Digital Exemplar programme, provides clinical leadership to the digital ‘Living Lab’, and has skills and knowledge in design thinking, system evaluation and developing collaborative partnerships with industry. In 2018, he graduated as part of Cohort 1 of the NHS Digital Academy

Over recent years, Jim has led the design and development of the NCA Digital Control Centre Programme; a transformational partnership that will embed advanced technologies and behaviours to optimise operational efficiency and improve care delivery. In addition, he has worked with colleagues to develop partnerships that can deliver new models of care for chronic disease into the NHS. This work includes development of the RevOCE programme which has delivered tools for population risk segmentation, targeted care and holistic multimorbidity clinics.

Natasha Sunderji is the Global Health Lead of Accenture’s social impact business, and also co-leads Accenture’s Health Equity Center of Excellence. She has 18+ years of experience advising companies, NGOs, donors, and multilaterals on social business model design, digital health, and cross-sectoral partnerships. She has designed patient centric solutions with leading health actors, developed 30+ inclusive businesses, and advised policy makers on the investments needed to create robust digital health ecosystems. She was named a World Summit AI Top 50 Innovator in 2020. Natasha holds a Bachelor’s in Biomedical Engineering from University of Toronto, and a Master’s in Public Policy from Harvard Kennedy School.

Elif is the Head of Computational Biology and Exploratory Analytics Products at Roche. She leads a global team of product managers that focus on building bioinformatics, omics and predictive analytics products that enable new hypothesis creation using state-of-the-art, interpretable and robust machine learning and advanced mathematical modeling approaches. 

Elif holds a BS and MS in Chemical Engineering from Bogazici University and a PhD in Structural Biology from Purdue University, where she used molecular dynamics simulations to study the Src kinase activation mechanism. She then joined the Chemical Engineering Department at Bogazici University as a faculty member. Her research spanned both experimental and computational studies on elucidating protein – compound interaction mechanisms and structure based drug design for proteins related to antimicrobial resistance and sphingolipid binding. She moved from >15 years in academia to industry when she joined Roche as the Head of Data Science in Go-to-market Data and Analytics in 2020. 

Valentina is a Partner in McKinsey’s Zurich office. Since joining in 2006, she has worked with multiple Healthcare and Life Sciences stakeholders, including Pharma companies, Health Tech start-ups, Hospitals and NGOs on a range of including how they can leverage advanced analytics to step-change their performance and operating model.

Valentina has been co-leading the QuantumBlack hub in Zurich since 2020, and it’s Digital and Analytics effort in Global Public Health. Valentina is passionate about the topic of diversity and leads Women Recruiting for the Swiss office as well as D&I for the Life Sciences Practice.

Peter Hackel leads the Data Products Team for Takeda’s Global Manufacturing Supply and Global Quality Organization. With his team he builds an environment where data analytics is possible and scalable across the organizational levels and pillars.

He brings more than 14 years of experience in the pharmaceutical industry working in areas such as process development, process optimization, technology deployment and data strategy. He believes the harnessing of technologies such as natural language processing or machine learning built on a sustainable data infrastructure is a differentiating factor in how companies can run operation and serve patients around the world.

Medical radiologist, enthusiast of health innovation with clinical experience in public and private health systems in Latin America and Europe. Since 2020 he has been working at Bayer Radiology.

Mr. Marco Obiso is the Head of the Cybersecurity division and currently acting as Chief of the Digital Network Society Department in the Telecommunication Development Bureau of the International Telecommunication Union (ITU), the lead UN-specialized agency for Information and Communication Technologies (ICT).

He has been working in the ICT field for the past two decades, operating in several ICT-related domains such as network infrastructure development, system integration, application cooperation, IT Service Management, Internet governance and information security.

As Head of the Cybersecurity division, he is currently facilitating the work of ITU in elaborating Cybersecurity strategies and implementing programmes and initiatives as well as leading the ITU’s efforts on enabling the use of ICT applications, for the benefit of ITU Member States, including providing technical assistance in establishing capabilities and working to strengthen coordination and cooperation within the UN system.

Giuseppe Marco Randazzo is a cheminformatic data scientist with more than 10+ experience in drug discovery. After completing his Ph.D. in chemical science at the laboratory of chemometrics and cheminformatic University of Perugia, in 2013 moved to the pharmaceutical sciences department of the University of Geneva for a post-doc position in the analytical chemistry group. He worked on machine-learning (ML)/cheminformatics tools for automatic compound annotation in metabolomics approaches. He also worked in a joint venture between the University of Geneva and a private industrial partner, Firmenich, delivering new active nature-identical compounds using ML and cheminformatics approaches. In 2017 he joined the Dalle Molle Institute for Artificial Intelligence in Lugano, developing new AI tools for drug discovery. In 2019 he joined F. Hoffmann-La Roche as a post-doc scientist to implement new machine-learning and AI methods for polypharmacology. In 2021 he joined Endogena Therapeutics in the role of Head of AI and Cheminformatics. He is an enthusiast and active open-source supporter, contributing to several scientific projects.

Patricia Gee leads Deloitte’s Future of Health initiative in Switzerland. She has spent over20 years in the life science and health industry, bringing together cross-sector experience in biopharma, payer, provider and capital markets. She focuses on driving sustainable value, growth and innovation for leading life science clients in the areas of commercial transformation, digital innovation, product launch, marketing, sales and market access.

Dr Andrew Soltan is an NIHR-funded practicing Clinician at Oxford University Hospitals NHS Trust, and Clinical Machine Learning Researcher at the University of Oxford. His research applies machine learning methods to Electronic Health Record data for rapid diagnosis and prognostication in acute and emergency care settings. During the COVID-19 pandemic, Dr Soltan led the CURIAL programme which developed and deployed an AI test to screen patients for infection in Emergency Departments, using clinical data routinely available within 1h. The CURIAL evidence base has achieved two publications in The Lancet Digital Health, showing a 26% reduction in time-to-result when piloted at the John Radcliffe Hospital and reduction in missed COVID-19 cases compared to Lateral Flow Testing alone.
Previously Dr Soltan has worked in industry as Medical Officer at Visulytix, which partnered with Orbis International to make its AI tool for detecting treatable eye disease accessible to doctors in low-resource countries. Since graduating with Distinction in Medicine from the University of Cambridge, Dr Soltan has received awards including an NIHR Academic Clinical Fellowship and a Translational Research award funded by the Wellcome Trust.

Sabina Magalini is a Surgeon of the Emergency and Trauma Surgery Department of the Policlinico Gemelli of Rome Italy (World’s Best Hospitals 2022, Newsweek) and an aggregate Professor of the Catholic University School of Medicine. 

Aside from clinical work she is interested in the organization of emergency medicine and surgery procedures in situations of disaster medicine. Together with her team she has participated in many EU projects dealing with CBRNe response (EDEN, ENCIRCLE, SMARTSTADIUM), decision support systems for first responders (FR) (PULSE, IMPRESS), development of new technologies for FR (NIGHTINGALE), security problems for communication during the pandemic (REACT2, COVINFORM), data sharing for research in medicine (TRUSTEE). 

The increasing importance of cybersecurity for hospital resilience has pushed her interests in the direction of identifying response and responsibilities of hospital personnel. She has coordinated the PANACEA project on people-centric hospital cyber resilience and will be part of the DYNAMO project on business continuity during cyberattacks. 

Partner in the EU Coordination Supporting Action Networks NO-FEAR, INCLUDING, EU-HYBNET, her main effort is in participation of medical personnel as end-users in technological projects in the medical security setting, because this interaction will guarantee the development of the best technology in an EU perspective.

Jacques Gilbert is the Senior Director of Healthcare Strategy at Nuance Communications. Jacques leads business development, strategic partnerships and M&A activities for Nuance’s Diagnostics business unit which includes a large portfolio of AI applications integrated into both clinical and administrative workflows for healthcare providers, pharmaceutical, payors and self-insurance employers and medTech customers. Prior to joining Nuance in 2017, Jacques cofounded start-ups in AI/ML and strategy consulting in financial services sector and more recently held multiple leadership roles in strategic marketing for GE Healthcare. He received Bachelor of Commerce degrees from University of the Witwatersrand in Johannesburg, South Africa

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

Nishant Sinha is a Director in AI and Data Strategy. He specializes in Artificial Intelligence, Automation, Machine Learning and Analytics Strategy. Nishant leverages his 20+ years of experience in Life Sciences consulting to support his clients successfully embark on data driven transformations, bringing a customer centric approach to the business process and model redesign enabled by Artificial Intelligence

Richard Plumb is a seasoned cyber and physical security speaker. After spending 15 years in the Police, he transitioned to cybersecurity consulting and threat intelligence. He now works as the Cyber Threat Intelligence Lead for NHS Digital, whose team provide cutting edge threat intelligence to the whole of the NHS, from senior leadership teams to the technical teams on the ground. Richard has extensive experience of communicating complex cybersecurity concepts to a wide range of audiences and enjoys making presentations both thought-inspiring and enjoyable.

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur. She is the founder and CEO of OKRA Technologies – an artificial intelligence data analytics company for healthcare. OKRA allows healthcare professionals to combine all their data in one place and generate actionable, evidence-based insights in real time, to save and improve human lives. Loubna is currently a member of the European Union High-Level Expert Group on Artificial Intelligence, where she is particularly focused on healthcare and achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and won several prizes, including CEO of Year 2019 at the Cambridge Independent Science and Technology Awards and Best Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a strong

advocate for diversity, women and challenging the status quo.

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery and biomarker development. Under his leadership Insilico raised over $380 million in multiple rounds from expert investors, opened R&D centers in six countries or regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions, nominated 8 preclinical candidates, and entered human clinical trials with AI-discovered novel target and AI-designed novel molecule. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic biological and patient data. Since 2012 he published over 160 peer-reviewed research papers, and 2 books.

He founded and co-chairs the Annual Aging Research, Drug Discovery and AI Forum (9th annual in 2022), the world’s largest event on aging in the pharmaceutical industry. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.

Thomas Lindahl is the Chief Medical Officer for Unilabs Sweden, a country leader in medical diagnostics. He did his training as a radiologist, as well as a PhD in oncology, at the Karolinska University hospital in Stockholm. After leaving academic medicine Thomas has held many leadership roles within the medical diagnostics business, including the Unilabs TMC on call teleradiology service in Sydney, Australia. His present role includes responsibility for AI and innovation strategy. Being an early AI adopter he has overseen the validation and clinical implementation of several AI tools for radiology and digital pathology.  Thomas is part of the steering comity for the Unilabs Group AI center of excellence.

Arnaud Wilmet, MD is Chief Medical Information Officer at Nuance where he is in charge of the France Medical Accounts. Prior joining the team, he managed a Pediatrics center in Paris for five years and implemented a full patient integrated EHR with success. He joined Cerner France where he applies clinical knowledge to facilitate development, marketing, sales and integration of solutions to improve patient outcomes and raise physician satisfaction in French Hospitals. He relocated 3 years in the USA as a Senior Physician Executive for Cerner Corp. working with major clients. His last role was Chief Medical Officer of H4D, a telehealth provider where he manages the virtual clinics and medical affairs. Dr Wilmet finished medical school at University of Angers as a family practice physician. The breadth of his background has given him a holistic perspective which encompasses both the patient and provider experience.

Ardy Arianpour is CEO & Co-Founder of Seqster the leading healthcare technology company that puts the patient at the center of all their health data. He is a visionary health tech executive with 20+ years driving innovation in biotech and digital health. 

Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion.

As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country.

Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management. He was a Medical, Marketing, and Media’s (MM&M) Top 40 Healthcare Transformer and San Diego Business Journal 40 under 40.

Omar Khawaja is passionate about people, community, frameworks, communication and measurement. Omar is currently Chief Information Security Officer (CISO) at Highmark Health, a blended health care delivery and financing system, employing more than 45,000 people and serving 50 million Americans. Prior to Highmark Health, Omar was at Verizon Enterprise Solutions, where he had product management and marketing responsibilities for their security solutions portfolio with customers in 72 countries.

In order to sustain the effective delivery of security controls at scale, Omar led the development of 14 frameworks and 8 measurement programs. For this focus on sustainability, Highmark’s Information Security & Risk Mgmt program has been profiled by: Wall Street Journal, SANS, Forrester, Gartner, NACD, Reuters, HIMSS, CSO Magazine and others.

Omar’s certifications include SAFe Agilist, human centered design practitioner, CPHIMS (Certified Professional in Healthcare Information and Management Systems), CISSP (Certified Information Systems Security Professional), CCSK (Certificate of Cloud Security Knowledge) and FAIR Risk. Omar has a BS in Electrical Engineering from Georgia Tech and an MBA from University of Virginia’s Darden School of Business.

Omar currently serves on the boards of HITRUST, the FAIR Institute and Leadership Pittsburgh; on the CISO Workgroup of the Blue Cross Blue Shield Association, as an advisor to a half dozen tech firms and as adjunct faculty for the Chief Information Security Officer (CISO) program at Carnegie Mellon University.

Dr Jacob J Visser is an experienced radiologist and proclaimed academician at the Erasmus Medical Center. He is also the Chief Medical Information Officer at the hospital and the Head of Imaging IT and Value-based imaging at the department of Radiology & Nuclear Medicine.  

Dr Visser has been working closely with the hospital & health care industry focused on Radiology since 2006 and has been associated with the legacy institution – Erasmus MC for the past decade. Dr Visser focuses on the intersection of health economics, technology with radiology and focuses on Telehealth, Clinical Informatics, Integrated Diagnostics, and Artificial Intelligence. He is a keen scholar and an illustrious member of many prestigious industry bodies for Radiology and Medical Imaging across the globe. He has written more than 20 critically acclaimed clinical research papers on radiology and nuclear medicine. 

LinkedIn: https://www.linkedin.com/in/jacob-j-visser-7455426/  

A bio-medical engineer and digital health enthusiast with a decade of experience in diagnostic imaging, radiology and Hospital AI. Having extensively worked with radiologists, clinicians, hospital administrations and health tech companies understands and contributes towards effective implementation of AI in healthcare services.

Stanisa Raspopovic is an Assistant Professor of Neuroengineering at the Department of Health Sciences and Technology of the Swiss Federal Institute of Technology, Zurich, Switzerland. He worked as a PostDoc at EPFL, Lausanne, Switzerland 2013-17. He received the MS in Biomedical Engineering with full marks from the University of Pisa, Italy, in 2007 and the Ph.D. cum laude in Biorobotics, from Scuola Superiore Sant’Anna, Pisa in 2011. His research interest is focused on the development of innovative medical devices for treatment of neurologically disabled persons. In particular, he develops mechatronic systems directly interfacing the environment with the residual nervous system. Stanisa achieved the groundbreaking translational research results in the field of sensory restoration in amputee patients. Driven by the desire to share these inventions with the wider population, in 2014 he co-founded SensArs Neuroprosthetics, a spin-off that develops neuroprosthetic systems, which won many international recognitions, and raised several millions of non-dilutive funding. He won several grants from EU and Switzerland in the role of a project leader and is presently the PI of the prestigious ERC starting grant FeelAgain.  

Anita is Product Manager at Omina Technologies. She is responsible for the product management of Justifai. Justifai is an AI as a Service platform that empowers business domain experts to co-create scalable, trustworthy and regulatory compliant AI innovations and bring them to value faster and more efficiently. 

Anita is passionate about AI, product management, innovation management and marketing. Before joining Omina Technologies, she worked as a product manager for NGDATA and Showpad. She also worked as an innovation manager for Boobook consulting. She holds a PhD in Business Administration and Management. She had an academic career in the field of AI and marketing at Ghent University, Manchester Business School and Monash University.

Sam was awarded his PhD in Systems Biology from the Department of Computer Science at the University of Oxford. He conducted research at the Biotech Information & Research Center in Copenhagen and Harvard Medical School on single-cell transcription data sets, and has over 5 years’ experience working in the pharmaceutical industry.

Sam has an extensive problem-solving and explorative toolkit, and he enjoys applying his knowledge in machine learning, R, Python, and drug R&D to challenging projects.

Sam is Head of Bioinformatics, Target & Biomarker Discovery at Abzu, the deep tech startup whose proprietary AI accelerates exploration with simple and explainable models, enabling scientists to bring drugs to market faster.

At home, Sam is an avid runner and is learning Danish by reading Rasmus Klump to his two kids.

Dr Suraj Kapa is the SVP of healthcare at TripleBlind. He practiced as a cardiac electrophysiologist at Mayo Clinic and over the course of his career he has published more than 200 peer-reviewed articles and book chapters, given 100s of invited lectures, and has filed over 30 patents resulting in startups and FDA approved technologies.

He is highly sought after for his views on the future of digital health and healthcare delivery, having advised multiple public companies and startups in digital strategy. Additionally, his work on digital tools to address the pandemic in 2020 and developing algorithms to enable early prediction of disease has been featured in major news outlets.

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and is responsible for Innovation within Deloitte Switzerland’s Executive team. His team helps clients leverage the power of artificial intelligence and data to deliver more customer-centric and innovative products and services that catalyse growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global transformations, leveraging new delivery models (GBS/SSC, outsourcing) and innovative technologies (e.g. robotics, machine learning, natural language processing/generation). He helps global organisations review and implement new strategies for business support functions and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

Sofiat Akinola is currently a Director of Health Policy and External Affairs at Roche Diagnostics. In this capacity, she works with decision-makers to advocate for access to timely screening and diagnostic tools to improve patient outcomes. Her portfolio includes cervical cancer, women’s health, health system strengthening and resilience, and universal health coverage.

Before joining Roche Diagnostics, Sofiat was a Global Health Lead at the World Economic Forum. Her portfolio focused on keeping populations healthy and health systems transformation – Value-Based Healthcare, Universal Health Coverage, and Healthy Ageing and Longevity. She led the Global Future Council on Healthy Ageing and Longevity at the World Economic Forum, a dynamic platform for leading businesses, governments, civil society organizations, and world-class experts to shape the global healthy aging and longevity agenda. In this capacity, she worked with the community to generate and disseminate new content and insights and engaged with multiple actors to co-create solutions to boost the impact of healthy life expectancy.

Sofiat also has extensive experience in the NGO and Government sectors. She used her monitoring and evaluation skills to support strategies ranging from Fetal Alcohol Spectrum Disorder Initiative to Ending Homeless in Alberta, Canada.

Sofiat has two Masters, one from the University of Oxford on Evidence-Based Social Intervention and Policy Evaluation with a focus on Impact Evaluation, and from Tulane University School of Public Health and Tropical Medicine, where she received her MPH. Sofiat received her Bachelor’s degree from McGill University in Sociology, focusing on Gender, Health, and International Development.

Cécile Tardy-Srinivasan leads the DayOne Health 4.0 Accelerator. In this role, she supports international digital health startups to scale up at the interface with biopharma companies. Passionate about advancing healthcare, her focus is on building bridges between the patients, clinicians, startups, and Pharma worlds to enable collaborations.

Previously, Cécile worked at major pharma companies, like Novartis, where she held various roles at country, regional and global levels. She brings a background in finance from working at EY. Striving to improve patients experience and outcomes, she specialized in co-creating solutions for patients and healthcare professionals, working with different stakeholders in the healthcare ecosystem.

Cécile studied Design Thinking at the MIT Sloan School of Management and holds a Master’s in Management from the EDHEC Business School France.

Curious to know more about DayOne Health 4.0 accelerator? More information available on https://www.dayone.swiss/dayone-accelerator/health-4-0/

Edwin has been working as a physiotherapist / healthcare innovator in the Amsterdam UMC university hospital since 1991. As a healthcare innovator he has initiated innovations that have led both to research projects and, when positively evaluated, have been implemented in daily practice; some local, some regional and some national. These innovations encompass projects based on changes in ‘regular’ healthcare as well as eHealth and recently also concern datascience related projects. Our pilot study to detect in hospital fall incidents is currently being implemented in the electronic health record of our hospital. Pubmed: https://pubmed.ncbi.nlm.nih.gov/?term=geleijn&sort=date

A biochemist and health economist with 30+ years in pharmaceutical research and development and experience in various health areas including cardio-vascular therapies and diagnostic imaging.

Valerie heads the business expansion and sales activities for Nuralogix Corporation across the EMEA and LATAM markets. Multi-disciplinary, multi-cultural and multi-lingual, she uses her vast and extensive experience in the various tech sectors over the years to provide a holistic approach when dealing with customers. An “out of the box” thinker and executor, she is a real believer that great professional and personal interactions is the key to long lasting successful business relationships which is reflected in her unique approach. The last few years within the Digital health space, she has been involved in numerous projects for the private and public health sector and has contributed significantly to the dynamic expansion and growth of Nuralogix.

Dr. Noa Hurvitz is a resident in the Department of Medicine at the Hebrew University-Hadassah Medical Center. She was educated in the Hebrew University-Hadassah medical school. Dr. Hurvitz has authored and participated in several clinical trials comprising second-generation artificial intelligence systems for improving the response to chronic medications and the development of digital twins.

Jürg Hutter works as Senior Product Manager in the Digital Health Business Unit at Swiss Post.

He has more than 20 years of experience in working with national and multinational companies in the field of digital health, healthcare, corporate social responsibility and climate change. Together with clients, he is on the road to establish healthcare eco-systems and bring digital health solutions to life. Jürg holds a Master in Environmental Sciences at the Swiss Federal Institute of Technology as well as a Master in Information- and Technology Management at University of St. Gallen.

Find more information about Swiss Post and Digital Health at https://www.post.ch/en/business-solutions/digital-health

Veysel is a Senior Data Scientist and Healthcare NLP Lead at John Snow Labs, improving the Spark NLP for the Healthcare library and delivering hands-on projects in Healthcare and Life Science. 

He is a seasoned data scientist with a strong background in every aspect of data science including machine learning, artificial intelligence, and big data with over ten years of experience. He’s also pursuing his Ph.D. in ML at Leiden University, Netherlands, and delivers graduate-level lectures in ML and Distributed Data Processing. He is also working towards his PhD in Computer Science and is a Google Developer Expert in Machine Learning.

Veysel has broad consulting experience in Statistics, Data Science, Software Architecture, DevOps, Machine Learning, and AI to several start-ups, boot camps, and companies around the globe. He also speaks at Data Science & AI events, conferences and workshops, and has delivered more than 20 talks at International as well as national conferences and meetups.

Associate Professor Sandeep Reddy is an Artificial Intelligence (AI) in Healthcare researcher based at the Deakin School of Medicine besides being the founder/chairman of Medi-AI, a globally focused AI company. He also functions as a certified health informatician and is a World Health Organisation recognised digital health expert. Further, he is a Fellow of the Australasian Institute of Digital Health and a certified health executive with the Australasian College of Health Service Management. He has a medical and healthcare management background and has completed machine learning/ health informatics training from various sources. He is currently engaged in research about the safety, quality and explainability of the application of AI in healthcare delivery in addition to developing AI models to treat and manage chronic diseases. Also, he has authored several articles and books about the use of AI in Medicine. Further, he has set up local and international forums to promote the use of AI in Healthcare in addition to sitting on various international committees focusing on AI in Healthcare.

Since joining the pharmaceutical Industry 25 years ago, Michael has covered roles of increasing responsibility in clinical research, medical affairs and strategic marketing and participated in new medicines launches, large development programs for small molecules and monoclonal antibodies and the day-to-day management of medical affairs, research and commercialisation at Country, Regional and Global level.

Michael pursued a postgraduate career in Surgery and Surgical Oncology in the UK and in Germany gaining an MD in myocardial preservation in 1989 and became a Fellow of the Royal College of Physicians and Surgeons in 1992. He also gained an MBA in 1999, a specialist registration in pharmaceutical medicine in 2005 and is a fellow of the Faculty of Pharmaceutical Medicine at the Royal College of Physicians and was awarded an honorable Global Fellowship in Medicine Development title in 2020

Michael has published scientific papers on the use of artificial intelligence in medicine, various hematology indications, surgery, breast cancer, sarcoma targeted small molecules, mToR and general aspects of pharmaceutical medicine

Mukesh co-founded Phable in 2018, along with his partner Sumit Sinha. Before founding Phable, Mukesh had extensive experience in market research and analytics having worked with Borderless Access and Kantar. During his career, Mukesh has pioneered new research methods and technologies for consumer behaviour tracking basis which he built a new multi-million-dollar revenue line that was eventually acquired by AC Nielsen for an undisclosed sum. Mukesh holds an engineering degree and masters from Birla Institute of Technology and Science, Pilani and is a part of the country’s young founders’ league. 

Anuraag has extensive experience in building technology products for Healthcare providers, payers, and beneficiaries. His work on reducing Health Insurance Fraud gave him a unique view into challenges of standardising healthcare data and later, at Practo, he worked extensively on simplifying EMR creation for practitioners at Hospitals and Private Practice. He has over 24 years of experience in building technology products for B2C & B2B applications in Education and Healthcare domains.  He is an alum of IIT-BHU Varanasi, India.

Mame Daba DIOUF, Business Unit and Project Manager

Engineer in computer networks and multimedia communication, Mame Daba Diouf has 8 years of experience in the field of ICT.

She has led around twenty “digital for impact” projects applied to solar energy, NGO and association management, banking, microfinance, trade, and mobile applications for social and behavior change.

Since 2018 at IT4LIFE she puts her skills to the service of this social enterprise : 28 programming languages and frameworks; Databases; Agile project management methods (SCRUM certified); and Project Management.

She is interested in applying innovative technologies to meet the needs of underserved populations, with a focus on women’s health and hygiene issues.

As Associate Director of the Changeons Les Règles programme, Daba has played a major role in resource management, strategic oversight, user testing of WeerWi mobile application, scope management, testing and feedback, personal data collection declarations follow-up. She looks forward to being part of future high-impact ICT projects that change the lives of millions of girls and women, particularly in Africa.

Kapsule co-founder with an eclectic background spanning medicine, law and machine learning. While working in an East African hospital, he identified many challenges in African healthcare. He then tried to understand the root causes and noticed a huge lack of data. Hannan then decided to find ways to capture and structure healthcare data to enable evidence-based decision making and drive patient outcomes.

A seasoned nurse practitioner with over 20 years experience who has dedicated her life to the improvement of healthcare for patients across the continent. She has also taught at many universities in Cameroon and Innocentia holds a Masters Degree in Internal Medicine and a Ph.D in Public Health.

Niels is Partner and Health Innovation Director in a global award-winning innovation studio. He has extensive experience in working in and with health start-ups through a wide-array of incubation trajectories. Associated to the Novartis Foundation’s HealthTech Hub in Kigali, he is currently serving as a Strategic Advisor for the African HealthTech Start-up “Klarah – The Uber for home care in Sub-Saharan Africa”. The Klarah solution guarantees peace-of-mind to Africans residing outside the continent, by allowing them to deliver quality home nursing care to their loved ones back at home.

Theophila oversees the design and development of E-Heza Data Solutions software and leads the scale up of E-Heza across health facilities and villages in Rwanda. She uses her exceptional leadership skills to bring together software designers, developers, implementation experts, and frontline health workers to successfully expand E-Heza. Since 2020, Despite the challenges associated with the covid-19 pandemic, her leadership led to a four-fold increase in the number of women and children served on E-Heza. She utilizes her expertise in stakeholder engagement to support the organization in external relations with new and existing partners, as well as the Rwandan government. She was chosen as a finalist for the Commonwealth Digital Health Awards 2020 and 2022. Theophila has a passion to build digital solutions that contribute to the improvement of health outcomes and community engagement through health systems digitalization.

Aloys Rukundo is the Founder & CEO at Hellomed a virtual medical Consultation Platform based in Kigali, Rwanda. Prior to this, Aloys Co-Founded Watotosmile Ltd a social enterprise improving literacy to children (girls) from low-income households. He holds a Bachelors’ Degree in Banking and Finance,  and is very passionate about improving Public Health in Africa using Technology. Aloys, loves travelling, spending time with family and watching basketball.

Over 30 years of executive experience with major listed corporation in the IT Industry.

Conducted business in almost 40 international markets within many business sectors (including over 20 sub-Sahara Africa markets and other developing economies).

Mr Clivate Maiba is a 23-year old Award-winning innovator and experienced clinician who is passionate about health promotion, disease prevention, entrepreneurship, and digital healthcare, he believes that preventive measures are always better to approach than curative care. He is currently pursuing a BSc. In public health and holds a diploma in clinical sciences.

He is a Co-founder and chief operations officer of Health Literacy Zambia, a non-profit organization that aims to promote health education and practices in vulnerable communities. Over 18,000 Zambians have so far benefited.

Mr. Maiba serves as an executive director at Denga Logistics limited, a digital health start-up optimizing and automating lab reports, a network of motorbikes, and drones connecting hard-to-reach health facilities with medical supplies, state-of-the-art laboratories, and state-of-the-art blood banks. Denga is on a mission of taking essential health services to hard-to-reach remote communities

Clive’s passion for innovations had led him to participate in two hackathons organized by the Massachusetts Institute of technology and a good number of hackathons.

He worked on a digital health project that would monitor chronic patients living with hypertension and diabetes in real time, he received business and technical support from ZICTA but along the way, he resorted to putting the project on hold.

Clivate has so far volunteered in numerous organizations both locally and internationally, in the year 2019, he was awarded an ambassadorship of hypertension. He volunteered as a student against COVID, he also volunteered at copper rose Zambia as a sexual and reproductive health rights advocate. He is a 2022 ambassador at Bukovinian International Medical Congress and a former hypertension ambassador at the international society of hypertension.

He has undergone leadership, business, and entrepreneurship training. He is a 2021 semi-finalist at Harvard Cross Roads Emerging leaders’ program, He is one of the 34 African fellows at the African Oxford Initiative-Health innovation program, a Young African Leadership initiative (YALI-RSA) Alumni, and an Award-winning innovator at the 2021 National Innovation Initiative (supported by; UNDP, UNFPA, ZICTA, PACRA, Finish Government). He is among the top 30 in the next Gen incubation program by the jacaranda hub from over 2000 participants.”

Founder of Insightiv, a Rwandan medical imaging diagnostics startup.  MIT Computer Science and Economics graduate, with years of experience as engineer and Researcher in areas of Artificial Intelligence and Machine Learning, and their applications in Health and Speech Recognition. Published author in world-class journals such as Frontiers of Artificial Intelligence.

Lucas Scherdel is a neuroscientist, health tech executive, board advisor and published academic with a passion for health innovation and technology. Previously he led Switzerland’s leading health tech accelerator, DayOne, founding a seed fund and leading to investments in 50+ deep tech ventures. He also led Bayer Consumer Health’s R&D portfolio for local brands and external innovation as a Global Vice President. He has previously led the World Economic Forum’s Global Coalition for Value in Healthcare and its executive board which represents $350 billion of global market share and has advised multiple VC funds, startups, academic and public institutions such as the World Health Organization, UK’s NHS, UCL Business School and the European Institute for Innovation and Technology. Lucas is currently a supervisory board member of EIT Health and was named on the Forbes List 30 under 30 in 2020 and has been featured in the Guardian and Forbes and published as an author for the Lancet, WHO, WEF, UNEP and Health Tech World.

Amos Ankrah MSC is Boston’s Solution Specialist focusing on Product Management within Boston Medical Systems (BMS). Amos has 25 plus years of experience working in IT, however, before commencing his career in IT he gained a degree in Biochemistry and Pharmacology at Kings College London.

Amos and his team are driving the evolution of Boston Medical Systems with the delivery of a novel approach to drive the detection of anomalies in large organs. This role enables Amos to work on two career passions, the evolution of IT technology and the application of AI in Pharmacology.

About Acrux Cyber Services

Mechanical ventilation saves lives but causes lung injury and pneumonia.

Solving these problems requires highly qualified specialists and constant monitoring of the patient, which is impossible.

Yana Kozis is the CEO & Founder of Debaby, a startup from Ukraine aimed to help women struggling with infertility by providing mental health support. 

Before starting her venture, she was a part of a start-up team in the childcare field. In addition to 5+years of Operations and Customer Support experience with SaaS products and the commerce field, she has 4 years of content creation experience and an MBA degree. 

She’s passionate about technological innovations in the reproductive health area and focused on creating a meaningful product that has an impact on one of the sustainable development goals.

Steven Truong is the Founder and CEO of VinBrain, a subsidiary of Vingroup, the largest conglomerate in Vietnam. He has been in the AI and software industry for more than 26 years and has held senior leadership positions in top technology companies in the USA and Canada, including Microsoft, Honeywell, and IntelliCommunities. Before he formed VinBrain, he was the Director of AI Incubation and Engineering at Microsoft in the USA, reporting directly to the VP of MSAI. Steven has led multi-development center teams at Microsoft. He has been a key innovation initiator for AI products that have been used by millions of users worldwide, such as Email Smart Reply and iRanker. Steven established VinBrain with the mission to infuse AI and IoT to improve human lives and productivity. He has led his team to deploy DrAid – the 1st AI-powered doctor assistant in Vietnam – to more than 100 hospitals across Vietnam and the USA. VinBrain also served thousands of Vietnamese COVID-19 patients through VinBrain’s second flagship product, AIviCare, for telehealth. VinBrain won ACM SIGAI Industry Award in 2021 – previously, Microsoft was the only winner.

Luca Emili is an entrepreneur and investor, Founder and current CEO of InSilicoTrials Technologies, a pioneering platform that leverages modeling and simulation to accelerate innovation in healthcare and life sciences.

From 2001 to 2010 he was CEO of Emaze, a cybersecurity company that became one of the market leaders in Italy by automating security analysis for complex networks and devices. He is member of the Cloud Security Consultative Group in EMA and is responsible for the RCA Research Collaboration Agreement between InSilicoTrials and the FDA. He also co-chairs the Good Simulation Practice Task Force within the Avicenna Alliance’s Policy Development Working Group, with the goal of driving a consensus approach toward standardization for reliable development and use of in silico solutions.

Dylan Johnston is the founder and CEO of MOD1 AG and one of Switzerland’s leading cybersecurity experts. His organisation provides strategic, tactical and operational consulting services in cybersecurity, privacy, risk management and regulatory compliance to organisations in the digital healthcare, MedTech, BioTech and pharmaceutical space.

Dylan has over 20 years of experience designing, executing and overseeing security and privacy programs for organisations in highly regulated business sectors, where a comprehensive, risk-based approach to protecting critical information assets is central to corporate missions and business success.

Dylan holds a B.Sc. in Business Information Technology from the University of Bedfordshire, an M.Sc. in Information Security at Royal Holloway, University of London, and is currently a doctoral candidate (Information Security) at the University of East London.

André has twenty years of cumulative professional experience, mainly in roles related to Marketing&Sales in the tech industry. As Chief Commercial Officer of Giotto.ai, he is part of a top-notch team on a mission to redefine how Humans and Artificial Intelligence should work together on healthcare regulatory activities.

After a Ph.D. in Machine Learning applied to healthcare and life sciences at ETH Zurich, Matteo Togninalli is now the Chief Operating Officer at Visium. He provides applied ML expertise to Visium’s clients and gives technical and strategic guidance to the delivery teams at Visium. With his academic experience from EPFL, Stanford, and ETH in combination with his professional track record, Matteo has helped many of Visium’s clients to translate business needs into technical solutions leading to various breakthroughs for Roche, Novartis, Incyte, and many more.

Theresa Reiker is Associate Director of Population Health at the Novartis Foundation. In her role, Theresa supports health systems across the globe in harnessing the power of data to improve the health of their populations.

As a former biologist, turned machine learning enthusiast, turned public health professional, Theresa is excited to build bridges between fields. The global quest to improve population health requires intersectoral collaborations between diverse partners. Theresa sees herself as a connecting node in this network. Through her academic training at the Universities of Oxford and Cambridge and her PhD at Swiss TPH, she attained broad expertise in using real-world data and computational techniques for health, but also in health systems and policy planning. Her expertise spans the applications in health planning of classical data science, genomics, simulations and AI methods. Publications: click here

Andrew Addison is a senior software engineer with nearly 30 years of experience in the financial services industry.  He graduated in Computational Science at St. Andrews University in 1990 and spent several years working in core development for a 4GL company specialising in compiler writing. With a deep understanding of technology, Andrew has developed and deployed high-volume distributed computational solutions for major investment banks such as Salomon Brothers, JP Morgan, Merrill Lynch, SwissRe, Bank of America, Deutsche Bank as well as several well-known hedge funds. Andrew is very well versed in the security risks that business face today and is in regular dialogue with like-minded individuals through his vast network.

Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research. As a researcher, he has published over 1,200 peer-reviewed articles, with more than 310,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.

In 2016, Topol was awarded a $207 million grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling 1 million participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. He was the founder of a new medical school at Cleveland Clinic, Lerner College of Medicine, with Case Western University. He has over 440,000 followers on Twitter (@EricTopol) where recently he has been reporting insights and research findings for COVID-19. Besides editing several textbooks, he has published 3 bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.

Dr. Laura Matz serves as the Chief Science and Technology Officer at Merck KGaA Darmstadt, Germany, a role that entails spearheading the innovation agenda of a distinguished science and technology enterprise with a heritage exceeding 350 years in chemistry, biotechnology, and integrated materials solutions. In her capacity, Laura collaborates closely with the Company Board and partners with Innovation Heads across Merck KGaA’s three leading industry verticals: Life Science, Healthcare, and Electronics. Her visionary leadership is instrumental in shaping the future of the enterprise, leveraging digital and AI/ML technologies to drive innovation, exploring new markets, fostering strategic partnerships, and developing cutting-edge capabilities and digital business models to deliver groundbreaking solutions. A recent notable achievement includes her role as CEO in launching Athinia™, a joint venture with Palantir, which introduced a pioneering data collaboration platform for the semiconductor ecosystem. Prior to assuming the role of CSTO, Laura held the position of Senior Vice President within EMD Electronics, previously Versum Materials and Air Products Electronics division. With over 20 years, of experience in semiconductor manufacturing and a decade dedicated to running semiconductor materials businesses, she has been driving force the advancements in the field, prioritizing robust R&D for business expansion. Beyond her role at Merck KGaA, Laura serves on the Board of Directors of transformative organizations. She’s a board member of AIChE (American Institute of Chemical Engineers) and of SEMI. Laura also serves as Director on the board of AION Labs.

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

Carolyn Starrett is CEO of Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.

Almost everything known today about what works for patients with cancer comes from the relative few who enroll in randomized controlled trials. Flatiron uses clinical and data science to improve lives by learning from the experience of every cancer patient. Insights from Flatiron’s U.S-derived real-world data and analyses support meaningful learnings relevant to a global cancer population, and have helped expand treatment alternatives for people with gastric, colorectal, esophageal, breast, and head and neck cancer. Through three international subsidiaries, Flatiron now also works to improve treatments and outcomes for cancer patients in Japan, Germany and the United Kingdom.

Carolyn became Flatiron CEO in April, succeeding the company’s co-founders and bringing a deep understanding of the challenges facing those on the cancer frontlines from her years leading the company’s community oncology business. Prior to joining Flatiron in 2016, Carolyn held senior strategy, product and operations roles at data and technology companies, and worked with healthcare and technology companies as a principal with Boston Consulting Group. Carolyn holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor’s degree from Brown University.

Le Lu received a Computer Science PhD in 2007 from Johns Hopkins University. During his first six years at Siemens, he made significant contributions to the company’s CT colonography and Lung CAD product lines. 

From 2013 to 2017, Dr. Lu served as a staff scientist in the Radiology and Imaging Sciences Department of the National Institutes of Health Clinical Center. He then went on to found Nvidia’s medical image analysis group and he held the position of senior research manager until June 2018. From 2018 to 2021, he was the Executive Director at PAII Inc., Bethesda Research lab, Maryland, USA which has become one of the leading industrial research labs in medical imaging. 

He is currently the global head of Medical AI R&D for Alibaba group. He was the main technical leader for two of the most-impactful public radiology image dataset releases (NIH ChestXray14, NIH DeepLesion 2018). 

He won NIH Clinical Center Director Award in 2017, NIH Mentor of the year award in 2015, and won numerous best paper awards in recent MICCAI and RSNA technical and clinical conferences from 2016 to 2021 (over 11600 citations). In 2021, He was elected into IEEE Fellow class cited for his contribution to machine learning for cancer detection and diagnosis, and MICCAI society board member (MICCAI-Industry Workgroup Chair). He is currently an Associate Editor for IEEE Trans. Pattern Analysis and Machine Intelligence and IEEE Signal Processing Letters. He has published more than 200 peer-reviewed articles and leading conference papers in Nature Communications, Clinical Cancer Research, IEEE TMI, MedIA, etc. He is the (co-)inventor of 69 USPTO/PCT patents (granted or pending).

Jeroen Tas is responsible for Strategic Business Development at Philips and former Chief Innovation & Strategy Officer at Philips. He has more than 35 years of global experience as an entrepreneur and executive in the healthcare, information technology and financial services industries.

Jeroen is closely involved with the company’s strategy, platforms, ventures and emerging businesses. In his current position in Strategic Business Development, he plays a central role in coaching digital business ventures and leadership and is involved in strategic projects to create new models of people-centric healthcare. He leverages emerging technologies such as artificial intelligence, robotics and the Internet of Things to reinforce the company’s health propositions aimed at supporting consumers, care professionals and health systems with personalized, connected health solutions. 

Jeroen’s stance is echoed in Philips’ commitment to touch the lives of billions and improve better health outcomes at lower cost: from healthy living and prevention to diagnosis, treatment and home care. 

A respected thought leader, Jeroen was responsible for turning around Philips’ healthcare IT business and has been instrumental in establishing HealthSuite as the new open industry standard for the ‘Healthcare Internet of Things’ Cloud platform.

Jeroen joined Philips in 2011, leading IT worldwide as Group Chief Information Officer (CIO). In 2014 he became CEO of Philips Healthcare, Informatics Solutions & Services, overseeing digital health and clinical informatics. From 2016, Jeroen led the company’s Connected Care and Informatics businesses, demonstrating a passion to create new models of people-centric healthcare, based on the power of information technology.

Before joining Philips, Jeroen co-founded and served as President, COO and Vice-Chairman of the board for MphasiS, an IT and Business Process Outsourcing company, which was acquired by HP in 2006. Prior to MphasiS, he was the head of Transaction Technology, Inc., Citigroup’s tech lab, responsible for the innovation and development of the bank’s customer-facing systems, including Internet banking and self-service devices. From 2007-8, he was Vice President and General Manager at EDS, responsible for the company’s global competency centers.

Sir Nigel Shadbolt is Principal of Jesus College and Professor of Computing Science at the University of Oxford, where he has centred his research in human centred AI in a wide range of applications.  Most recently he was asked to lead the setting up of the Oxford Institute of Ethics in AI.  He is also the Chairman and Co-Founder of the Open Data Institute (ODI).  Since 2009, Sir Nigel has helped transform public access to Government information.

In 2010, he joined the UK government’s Public Sector Transparency Board – overseeing Open Data releases across the public sector.  He was knighted in 2013 for ‘services to science and engineering’. 

With over 500 publications, he has researched and published on topics ranging from cognitive psychology to computational neuroscience, Artificial Intelligence to the Semantic Web.  In 2018 he published The Digital Ape: how to live (in peace) with smart machines, described as a ‘landmark book’.

He is a Fellow of The Royal Society, the Royal Academy of Engineering and the British Computer Society.

Dr. Junaid is a practicing physician in the NHS and is also the Chief Medical Scientist at Microsoft Research. He also serves as a Non-Executive Director at University College London Hospitals NHS Foundation Trust. He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their global digital strategy. Junaid also has experience in the academic world where he is a Clinical Associate Professor at University College London (UCL), and a Visiting Scientist at the Harvard School of Public Health. Over the past 15 years, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer,and policy maker within the UK, where he specialised in informatics, digital transformation, and leadership. He has also acted as a consultant for health care systems across the US, Australia, New Zealand, Singapore, the Middle East, and Europe.

Dr. Lungren is the Co-Director of the Stanford Center for Artificial Intelligence in Medicine and Imaging and Medical School Faculty in the Department of Radiology at Stanford University Medical Center. Dr. Lungren’s NIH and NSF funded research is in the field of AI and deep learning in medical imaging, precision medicine, and predictive health outcomes. His work has been featured in national news outlets such as NPR, Vice News, Scientific American and he regularly speaks at national and international scientific meetings on the topic of AI in healthcare.

Effy Vayena is a Professor of Bioethics at the Swiss Federal Institute of Technology (ETHZ) and renowned expert at the intersection of medicine, data, and ethics. Her work focuses on how emerging technologies in biomedicine and data analytics affect our society and what ethical safeguards we should put in place to avoid negative consequences. To address these questions, she uses different research methodologies. She founded and directs the Health Ethics and policy Lab, an interdisciplinary research lab including philosophers, social scientists, lawyers, biologists and engineers.

Vayena has been appointed Faculty Associate at the Berkman Klein Center for Internet & Society at Harvard University, where she was previously a Fellow. She has published over a hundred peer-reviewed articles and book chapters and co-edited several books. Vayena is also an elected member of the Swiss Academy of Medical Sciences. She chairs the Ethical, Legal and Societal Implications advisory group for the Swiss Personalized Health Network, a national infrastructure and research program which aims to advance personalized healthcare in Switzerland. She currently co-chairs the WHO’s expert advisory group on Artificial Intelligence health ethics and governance. She is also a member of the Swiss COVID19 Science Task. Vayena frequently advises governments and public policy organizations on matters of digitization and ethics.

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program.  From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone). From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic.  Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala.  

Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts.  Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries.  Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

Pieter Jeekel is chairman of the Netherlands AI Coalition for Well-being & Healthcare and director and founder of Evodoc and The Social Health Company. Pieter has a background as an eHealth entrepreneur and leader of nationwide healthcare reform programs.

Eleonora is Head of Collaborations of NHSX’s AI Lab. Her work focuses on communicating and engaging with health and care professionals, the public and industry to support and share the work of the NHS AI Lab and the potential of AI. She has co-authored papers on AI in the NHS, the value of healthcare data, commercial models in healthcare and the regulation of data-driven technologies. She is a member of the British Standards Institution’s Committee on Artificial Intelligence and the London Hub Lead of One HealthTech, a grassroots community which seeks to promote diversity in healthtech.

Prof. Dr. Max Welling is a research chair in Machine Learning at the University of Amsterdam and a VP Technologies at Qualcomm. He has a secondary appointment as a fellow at the Canadian Institute for Advanced Research (CIFAR). Max Welling has served as associate editor in chief of IEEE TPAMI from 2011-2015. He serves on the board of the Neurips foundation since 2015 and has been program chair and general chair of Neurips in 2013 and 2014 respectively. He was also program chair of AISTATS in 2009 and ECCV in 2016 and general chair of MIDL 2018. He is a founding board member of ELLIS. Max Welling is recipient of the ECCV Koenderink Prize in 2010. He directs the Amsterdam Machine Learning Lab (AMLAB) and co-directs the Qualcomm-UvA deep learning lab (QUVA) and the Bosch-UvA Deep Learning lab (DELTA). He is a fellow and founding board member of the European Lab for learning and Intelligent systems (ELLIS).

Naomi Lee is a Senior Executive Editor at The Lancet. She heads the research section of the journal, and handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, oncology, digital medicine/AI, and medical technology.  She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health. Naomi joined The Lancet in 2014. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the UK. She has completed fellowships in Argentina and Mexico. She has also studied data science at University College London.

Dr Stefan Germann is the CEO of Fondation Botnar, a Swiss-based foundation which champions the use of AI and digital technology to improve the wellbeing of young people in urban environments. To achieve this, the foundation supports research, catalyses diverse partners, and invests in scalable solutions around the world.

Dr Germann has spent over 25 years working in various leadership roles in Africa and Asia, focusing on health-related development for children, relief and advocacy work. He was previously the Senior Director of World Vision’s International Sustainable Health Partnership, Innovation and Accountability unit based in Malaysia. His work focused on a complex relief and reconstruction program in response to the Asian Tsunami. 

He has previously held several board and advisory board memberships. These include for the Partnership for Maternal, Newborn and Child Health (PMNCH), UBS Optimus Foundation, REPSSI in Africa, the Global Health Program and The Graduate Institute in Geneva, where he focused on the role of NGOs in global health diplomacy.

Emmanuel Akpakwu has been the Chief Commercial Officer for Novartis’s SubSaharan Africa region since April 1st 2020. Reporting to the Regional Head, he and his team are responsible for driving the Commercial Strategy and execution of Novartis’s Sub-Saharan Africa mandate to expand patient reach across the full income pyramid and reach the full billion.

Emmanuel joined Novartis in January 2019 as Director of Corporate Strategy, reporting to the Head of Corporate Strategy. Prior to that, he led the Value-Based Healthcare Practice of the World Economic Forum in Geneva and was Associate Director of Corporate Strategy at Merck. His career started at JP Morgan Investment Bank in London.

Emmanuel holds a Bachelor of Science in Computer Science from the University of Hertfordshire, England and an M.Phil./MBA from the University of Cambridge, England. He also completed an Advanced Executive Education Certificate in Value Measurement for Healthcare from Harvard Business School.

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

Chris is a data scientist and developer at TPP and holds a PhD in Mathematics from the University of Manchester. Chris leads TPP’s work in the use of EHR data to support analytics, research, and surveillance. He has previously been recognised by the Health Service Journal (HSJ) as one of the top 50 innovators in UK healthcare.

In recent years, Chris led the TPP team which contributed to the development of the national Electronic Frailty Index (eFI). He is involved in a number of national research programmes, including in cancer survivorship and antimicrobial resistance. He works closely with the UK Biobank team, helping to combine EHR data with genomic information to support their vital research.